This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Foreign body in respiratory tract
ST19_FOREI_BODY_RESPI_TRACT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2153 |
4. Check minimum number of eventsNone |
2153 |
5. Include endpointsNone |
2153 |
6. Filter based on genotype QC (FinnGen only) |
2064 |
Control definitions (FinnGen only)
- Control exclude
- ST19_EFFEC_FOREI_BODY_ENTERING_NATURAL_ORIFI
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T1[5-9]
- Name in latin
- Corpus alienum viarum respiratoriarum
Similar endpoints
↥List of similar endpoints to
Foreign body in respiratory tract
based on the number of shared cases.
Similar with more cases:
- Effects of foreign body entering through natural orifice
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2064 | 1247 | 817 |
| Unadjusted period prevalence (%) | 0.42 | 0.44 | 0.37 |
| Median age at first event (years) | 49.94 | 47.03 | 54.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2153
- Matched controls
- 21529
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
W44
ICD-10 Finland
Foreign body entering into or through eye or natural orifice
203.3
307.7
547
36
T17.2
ICD-10 Finland
Foreign body in pharynx
5594.7
307.7
1156
5
T17.3
ICD-10 Finland
Foreign body in larynx
3109.3
300.0
283
*
T17.9
ICD-10 Finland
Foreign body in respiratory tract, part unspecified
1424.8
264.1
252
*
T17.1
ICD-10 Finland
Foreign body in nostril
2427.8
241.1
229
*
UJC02
NOMESCO Finland
Rigid oesophagoscopy
28.3
154.9
105
39
T17.4
ICD-10 Finland
Foreign body in trachea
+∞
146.6
139
*
T18.1
ICD-10 Finland
Foreign body in oesophagus
477.1
136.8
135
*
T17.5
ICD-10 Finland
Foreign body in bronchus
+∞
135.9
129
*
W79
ICD-10 Finland
Inhalation and ingestion of food causing obstruction of respiratory tract
167.1
106.3
111
7
W80
ICD-10 Finland
Inhalation and ingestion of other objects causing obstruction of respiratory tract
319.1
90.5
91
*
UGC02
NOMESCO Finland
Rigid bronchoscopy
20.5
75.9
58
29
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.6
69.6
248
745
UJC01
NOMESCO Finland
Scopy of lower throat
10.9
62.1
67
63
T17.0
ICD-10 Finland
Foreign body in nasal sinus
+∞
60.7
58
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
59.7
537
2644
T17.8
ICD-10 Finland
Foreign body in other and multiple parts of respiratory tract
509.5
50.6
50
*
R13
ICD-10 Finland
Dysphagia
3.1
48.8
217
744
X58
ICD-10 Finland
Exposure to other specified factors
2.3
43.9
414
2051
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
40.3
205
756
ENC10
NOMESCO Finland
Removal of foreign body from pharynx
+∞
38.7
37
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.9
34.4
167
599
W45
ICD-10 Finland
Foreign body or object entering through skin
5.3
32.9
67
130
T18.9
ICD-10 Finland
Foreign body in alimentary tract, part unspecified
152.0
28.7
30
*
GCA12
NOMESCO Finland
Bronchoscopic removal of foreign body
146.9
27.7
29
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
27.5
817
5761
ZXD05
NOMESCO Finland
Urgent procedure
1.7
26.8
638
4237
R87
ICPC
Foreign body nose/larynx/bronchus
60.8
26.0
30
5
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
45.5
22.4
27
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
22.0
950
7222
A02BC05
ATC
esomeprazole; systemic
1.6
21.9
801
5860
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
21.3
524
3474
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
21.0
580
3960
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
20.5
566
3859
R07.0
ICD-10 Finland
Pain in throat
2.1
18.3
188
948
R06.0
ICD-10 Finland
Dyspnoea
1.6
17.9
553
3855
J01FA10
ATC
azithromycin; systemic
1.5
17.9
1238
10234
DMC00
NOMESCO Finland
Removal of foreign body from maxillary antrum
181.4
17.5
18
*
W49
ICD-10 Finland
Exposure to other and unspecified inanimate mechanical forces
3.9
17.3
51
134
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.2
17.2
158
762
M79.6
ICD-10 Finland
Pain in limb
1.5
17.1
900
7020
Z2221
NOMESCO Finland
Medical doctor
1.6
16.9
555
3915
R01AD08
ATC
fluticasone; nasal
1.6
16.9
575
4090
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.9
16.7
49
128
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
16.6
382
2472
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
16.0
171
874
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
16.0
312
1932
GBA12
NOMESCO Finland
Endoscopic removal of foreign body from trachea
+∞
15.6
15
*
A02BC02
ATC
pantoprazole; systemic
1.5
15.3
1323
11257
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
15.2
513
3629
J01CA04
ATC
amoxicillin; systemic
1.6
15.2
1749
15757
N02AX02
ATC
tramadol; systemic, rectal
1.5
15.1
799
6193
M25.5
ICD-10 Finland
Pain in joint
1.5
15.1
679
5098
J01AA02
ATC
doxycycline; systemic
1.5
15.0
1498
13072
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
15.0
277
1687
UJC12
NOMESCO Finland
Flexible oesophagoscopy
5.7
14.6
27
48
R01AD09
ATC
mometasone; nasal
1.4
14.5
920
7363
N05CD07
ATC
temazepam; oral
1.9
14.5
207
1167
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
14.3
299
1884
J02AC01
ATC
fluconazole; systemic
1.4
14.1
748
5782
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
14.1
188
1037
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.6
13.9
83
332
S29
ICPC
Skin symptom/complaint other
1.6
13.9
427
2953
Y94.0
ICD-10 Finland
Accident at home
3.4
13.8
50
151
R51.80
ICD-10 Finland
Headache
1.6
13.8
347
2289
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
13.8
1099
9135
J01FF01
ATC
clindamycin; systemic
1.5
13.7
512
3690
K07.60
ICD-10 Finland
Snapping jaw
2.1
13.6
126
610
DHC00
NOMESCO Finland
Removal of penetrating foreign body from nose
75.6
13.6
15
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.6
13.1
76
300
R03AC02
ATC
salbutamol; inhalant
1.4
13.0
1130
9493
N05BA01
ATC
diazepam; systemic, rectal
1.7
12.9
248
1524
G44.2
ICD-10 Finland
Tension-type headache
1.7
12.9
285
1818
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
12.9
795
6292
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
12.9
208
1217
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
12.9
385
2641
Z3231
NOMESCO Finland
Registered nurse
1.5
12.8
537
3958
J01DB01
ATC
cefalexin; oral
1.5
12.7
1694
15323
N05BA04
ATC
oxazepam; oral
1.5
12.7
502
3656
J01MA02
ATC
ciprofloxacin; systemic
1.4
12.6
702
5452
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.6
12.6
74
294
R42
ICD-10 Finland
Dizziness and giddiness
1.5
12.5
430
3038
M54.5
ICD-10 Finland
Low back pain
1.4
12.5
722
5640
H02AB06
ATC
prednisolone; systemic
1.4
12.4
903
7342
N03AX16
ATC
[U] pregabalin
1.5
12.3
415
2922
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.0
12.2
143
755
R03BA01
ATC
beclometasone; inhalant
1.7
12.0
260
1648
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
3.2
11.9
46
145
Z3226
NOMESCO Finland
Physiotherapist
1.5
11.9
356
2441
M01AB05
ATC
diclofenac; systemic, rectal
1.4
11.8
1229
10562
J01FA06
ATC
roxithromycin; oral
1.4
11.8
724
5703
H02AB04
ATC
methylprednisolone; systemic
1.6
11.7
265
1699
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
11.7
523
3891
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
11.7
598
4564
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
11.6
482
3536
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
11.6
233
1450
J45
ICD-10 Finland
Asthma
1.7
11.5
213
1296
ZXE00
NOMESCO Finland
One hour or less
1.4
11.4
743
5907
N03AF01
ATC
carbamazepine; oral, rectal
2.2
11.3
97
456
R52.9
ICD-10 Finland
Pain, unspecified
1.7
11.2
208
1265
ZXA05
NOMESCO Finland
Left side
1.5
11.2
428
3084
M03BX02
ATC
tizanidine; oral
1.4
11.2
1162
9943
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
11.2
272
1774
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
11.1
384
2710
D79
ICPC
Foreign body digestive system
20.1
11.1
16
8
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
10.9
376
2653
J05AB11
ATC
valaciclovir; oral
1.6
10.9
279
1843
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
10.9
507
3794
R21
ICPC
Throat symptom/complaint
1.4
10.8
492
3665
S06.0
ICD-10 Finland
Concussion
1.7
10.8
228
1437
W84
ICD-10 Finland
Unspecified threat to breathing
10.6
10.8
20
19
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
10.7
385
2739
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
10.6
592
4574
T15.0
ICD-10 Finland
Foreign body in cornea
3.8
10.5
31
82
T17
ICD-10 Finland
Foreign body in respiratory tract
+∞
10.4
10
*
T18.2
ICD-10 Finland
Foreign body in stomach
+∞
10.4
10
*
X57
ICD-10 Finland
Unspecified privation
2.8
10.4
51
185
R03DC03
ATC
montelukast; oral
1.5
10.4
331
2296
EMB10
NOMESCO Finland
Tonsillectomy
1.9
10.4
128
689
UKC02
NOMESCO Finland
Cystoscopy
1.6
10.3
263
1735
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
3.5
10.3
35
102
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
10.2
1080
9219
R68.2
ICD-10 Finland
Dry mouth, unspecified
5.3
10.1
20
38
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
10.1
342
2402
A02BC03
ATC
lansoprazole; oral
1.4
9.9
495
3746
R03DA04
ATC
theophylline; systemic, rectal
2.1
9.8
92
450
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
9.8
140
791
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.6
9.7
212
1347
R07.3
ICD-10 Finland
Other chest pain
1.6
9.7
205
1292
E0000UV, ,
ATC
1.3
9.7
832
6866
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
9.6
431
3193
R35
ICD-10 Finland
Polyuria
1.9
9.6
128
706
N06AB04
ATC
citalopram; systemic
1.5
9.6
363
2606
R4110
NOMESCO Finland
Physiotherapy
1.4
9.5
517
3963
N03AE01
ATC
clonazepam; systemic
2.0
9.5
105
545
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.2
9.5
74
336
XQ800
NOMESCO Finland
Prick test
1.8
9.5
156
919
L12
ICPC
Hand/finger symptom/complaint
1.5
9.4
366
2640
EMC10
NOMESCO Finland
Removal of foreign body from tonsil
+∞
9.4
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
9.4
381
2773
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
9.2
120
657
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
9.2
681
5481
T15.1
ICD-10 Finland
Foreign body in conjunctival sac
3.8
9.2
27
71
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.2
814
6735
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
9.1
172
1051
N06AX21
ATC
duloxetine; oral
1.6
9.0
227
1491
R74
ICPC
Upper respiratory infection acute
1.3
9.0
705
5720
J45.1
ICD-10 Finland
Nonallergic asthma
1.8
9.0
147
863
R02
ICPC
Shortness of breath/dyspnoea
1.5
9.0
262
1782
AA1AD
NOMESCO Finland
CT of head and brain
1.4
8.9
499
3838
J01FA09
ATC
clarithromycin; systemic
1.4
8.9
589
4656
J01DA01
ATC
[U] cefalexin
1.3
8.9
1157
10092
L03
ICPC
Low back symptom/complaint
1.4
8.8
579
4570
M01AE02
ATC
naproxen; oral, rectal
1.3
8.8
1133
9857
N30.0
ICD-10 Finland
Acute cystitis
1.5
8.7
339
2442
Z71.8
ICD-10 Finland
Other specified counselling
1.3
8.7
685
5558
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
8.7
614
4904
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
8.6
171
1059
K59.0
ICD-10 Finland
Constipation
1.9
8.6
109
592
M79.1
ICD-10 Finland
Myalgia
1.5
8.6
294
2065
R01AD05
ATC
budesonide; nasal
1.8
8.6
140
822
H01
ICPC
Ear pain/earache
1.5
8.6
263
1807
N03AX09
ATC
lamotrigine; oral
1.9
8.5
104
558
L17
ICPC
Foot/toe symptom/complaint
1.4
8.5
598
4765
H02AB07
ATC
prednisone; oral
1.5
8.5
238
1602
R03BA02
ATC
budesonide; inhalant
1.4
8.5
342
2481
R01AD58
ATC
fluticasone, combinations; nasal
1.4
8.5
493
3814
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
8.5
829
6934
A02BC04
ATC
rabeprazole; oral
1.7
8.4
166
1027
A02BC01
ATC
omeprazole; systemic
1.4
8.4
472
3630
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.9
8.4
39
138
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
8.4
194
1251
R03AC03
ATC
terbutaline; inhalant
1.5
8.4
253
1733
R03BA05
ATC
fluticasone; inhalant
1.4
8.3
352
2575
R96
ICPC
Asthma
1.6
8.3
189
1212
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
8.3
118
665
Z01.2
ICD-10 Finland
Dental examination
1.3
8.3
959
8201
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
8.2
586
4680
N02BE01
ATC
paracetamol; systemic, rectal
1.4
8.2
1788
16706
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
8.1
193
1252
G47.3
ICD-10 Finland
Sleep apnoea
1.4
8.1
399
3000
ZXA00
NOMESCO Finland
Right side
1.4
8.1
442
3383
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
8.0
291
2068
K30
ICD-10 Finland
Functional dyspepsia
1.6
8.0
214
1426
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
7.9
111
623
G04BD11
ATC
fesoterodine; oral
2.5
7.9
48
195
R51
ICD-10 Finland
Headache
1.8
7.9
115
654
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.7
7.8
148
906
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.8
285
2028
R03BB04
ATC
tiotropium bromide; inhalant
1.6
7.7
170
1082
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.7
7.7
154
957
UDQ02
NOMESCO Finland
Direct laryngoscopy
3.6
7.7
25
71
A07AA02
ATC
nystatin; oral
1.9
7.7
99
542
R00.2
ICD-10 Finland
Palpitations
1.7
7.7
155
966
GBB00
NOMESCO Finland
Tracheostomy
3.4
7.7
27
81
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
3.7
7.6
23
62
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
7.6
335
2467
N05CF01
ATC
zopiclone; oral
1.3
7.6
541
4309
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
7.6
891
7604
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
7.6
1468
13366
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
7.6
255
1786
J35.0
ICD-10 Finland
Chronic tonsillitis
1.8
7.5
108
611
A06AD11
ATC
lactulose; oral
1.5
7.5
245
1703
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.3
7.5
52
225
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
7.5
391
2966
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.3
7.5
57
257
C07AA05
ATC
propranolol; systemic
1.4
7.5
379
2861
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
7.4
738
6163
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
7.4
318
2334
N06AB10
ATC
escitalopram; oral
1.4
7.4
395
3010
H57.1
ICD-10 Finland
Ocular pain
2.0
7.3
79
407
K08.80
ICD-10 Finland
Toothache NOS
1.6
7.3
173
1120
N04AA02
ATC
biperiden; systemic
2.7
7.3
38
143
J01MA12
ATC
levofloxacin; systemic
1.4
7.3
301
2191
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
4.2
7.3
19
46
J20
ICD-10 Finland
Acute bronchitis
1.6
7.2
187
1237
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
7.2
386
2940
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.7
7.2
115
673
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
7.1
462
3624
N05AX12
ATC
aripiprazole; systemic
1.9
7.1
86
461
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
7.1
138
851
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
3.4
7.1
25
75
N06AA09
ATC
amitriptyline; systemic
1.6
7.1
155
985
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
7.1
129
782
W19
ICD-10 Finland
Unspecified fall
1.5
7.1
189
1259
L01
ICPC
Neck symptom/complaint
1.4
7.1
316
2332
K22.2
ICD-10 Finland
Oesophageal obstruction
4.1
7.1
19
47
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.0
7.1
72
364
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
7.1
178
1171
J01EA01
ATC
trimethoprim; systemic
1.4
7.0
450
3524
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
7.0
623
5115
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.2
7.0
59
278
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
7.0
448
3509
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
7.0
129
786
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
7.0
126
763
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
7.0
188
1256
N06AX11
ATC
mirtazapine; oral
1.3
6.9
620
5091
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
6.9
62
299
Z43.0
ICD-10 Finland
Attention to tracheostomy
13.8
6.9
11
8
R06AX13
ATC
loratadine; oral
1.4
6.9
274
1981
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
6.9
430
3354
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.8
6.9
106
614
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.5
6.9
211
1450
D21
ICPC
Swallowing problem
2.7
6.8
35
131
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.8
457
3601
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
6.8
93
519
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
2.7
6.8
36
137
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
6.8
381
2921
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.9
6.8
84
455
Z2446
NOMESCO Finland
Social worker
1.6
6.8
138
863
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
6.7
257
1843
S83.2
ICD-10 Finland
Tear of meniscus, current
1.7
6.7
121
733
N03AX12
ATC
[U] gabapentin; oral
1.4
6.7
271
1965
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
6.7
104
604
M77.1
ICD-10 Finland
Lateral epicondylitis
1.6
6.7
135
842
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.7
6.7
109
642
TDH60
NOMESCO Finland
Removal of foreign body of nose
22.6
6.7
9
*
N05AH04
ATC
quetiapine; oral
1.4
6.7
338
2549
D19
ICPC
Teeth/gum symptom/complaint
1.3
6.7
611
5030
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
6.6
234
1654
A01AB09
ATC
miconazole; local oral
1.6
6.6
150
963
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
6.6
178
1190
D02
ICPC
Abdominal pain epigastric
1.7
6.6
123
752
ZXA10
NOMESCO Finland
Bilateral
1.4
6.6
318
2379
U07
ICPC
Urine symptom/complaint other
1.6
6.6
150
965
Y34
ICD-10 Finland
Unspecified event, undetermined intent
4.2
6.5
17
41
H50.1
ICD-10 Finland
Divergent concomitant strabismus
4.2
6.5
17
41
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
6.5
334
2521
M02AA07
ATC
piroxicam; topical
1.3
6.5
579
4743
L86
ICPC
Back syndrome with radiating pain
1.7
6.5
108
639
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
6.5
192
1310
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
6.4
85
470
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
6.4
88
492
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.5
6.4
209
1454
L02
ICPC
Back symptom/complaint
1.5
6.4
209
1454
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
6.4
288
2128
XF402
NOMESCO Finland
ECG with work load test
1.6
6.4
162
1069
I86.1
ICD-10 Finland
Scrotal varices
3.6
6.3
20
56
J01MA14
ATC
moxifloxacin; systemic
1.6
6.3
150
975
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.5
6.3
176
1186
R05
ICPC
Cough
1.3
6.3
487
3915
H16.0
ICD-10 Finland
Corneal ulcer
1.8
6.3
90
511
SPAT1301
SPAT
No procedures
1.3
6.3
564
4626
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
6.3
146
944
DQC00
NOMESCO Finland
Removal of foreign body from larynx
+∞
6.3
6
*
T71
ICD-10 Finland
Asphyxiation
+∞
6.3
6
*
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
26.7
6.2
8
*
H29
ICPC
Ear symptom/complaint other
1.5
6.2
225
1597
S21
ICPC
Skin texture symptom/complaint
1.4
6.2
280
2070
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
6.2
278
2053
J01DA09
ATC
[U] cefadroxil
1.3
6.2
458
3658
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
6.2
202
1407
R83
ICPC
Respiratory infection other
1.3
6.1
520
4233
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
6.1
186
1277
R06AE07
ATC
cetirizine; oral
1.3
6.1
839
7249
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
6.0
144
936
J01CA08
ATC
pivmecillinam; oral
1.3
6.0
735
6257
F29
ICPC
Eye symptom/complaint other
1.5
6.0
203
1422
J01DA06
ATC
[U] cefuroxime
1.4
6.0
237
1710
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
6.0
168
1132
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Emergency Room Visit
ER [9203]
ER [9203]
6.1e-01
6.9e-01
1.4e+00
8.2e+00
1.8e+00
6.0e-01
6.6e-01
cases:43.38%
controls:29.42%
cases:19.24%
controls:10.69%
cases:5.57%
controls:1.38%
cases:68.13%
controls:0.06%
cases:8.41%
controls:1.47%
cases:18.05%
controls:10.75%
cases:44.41%
controls:29.22%
869
5853
1134
14042
387
2133
1624
17820
112
275
1899
19678
1370
12
641
19941
166
293
1808
19622
346
2098
1571
17418
771
5143
965
12457
Emergency Medicine
93 [38004510]
93 [38004510]
4.2e-01
6.9e-01
1.4e+00
6.3e+00
1.1e+00
5.6e-01
4.8e-01
cases:12.68%
controls:8.72%
cases:8.65%
controls:4.52%
cases:2.88%
controls:0.70%
cases:14.27%
controls:0.03%
cases:2.13%
controls:0.72%
cases:8.35%
controls:4.94%
cases:20.56%
controls:13.76%
254
1734
1749
18161
174
902
1837
19051
58
139
1953
19814
287
6
1724
19947
42
144
1932
19771
160
964
1757
18552
357
2422
1379
15178
Pulmonary Disease
29 [38004472]
29 [38004472]
6.5e-01
7.5e-01
1.3e+00
4.4e+00
1.4e+00
6.9e-01
6.5e-01
cases:11.33%
controls:6.27%
cases:6.51%
controls:3.19%
cases:2.24%
controls:0.59%
cases:2.49%
controls:0.03%
cases:2.38%
controls:0.57%
cases:6.42%
controls:3.33%
cases:13.25%
controls:7.37%
227
1247
1776
18648
131
636
1880
19317
45
118
1966
19835
50
6
1961
19947
47
114
1927
19801
123
650
1794
18866
230
1297
1506
16303
Dysphagia
R13 [45573013]
R13 [45573013]
1.2e+00
1.3e+00
—
1.0e+50
3.3e+00
2.7e+00
1.3e+00
cases:1.25%
controls:0.37%
cases:0.65%
controls:0.17%
—
—
cases:0.90%
controls:0.00%
cases:0.71%
controls:0.03%
cases:1.67%
controls:0.11%
cases:2.02%
controls:0.56%
25
74
1978
19821
13
34
1998
19919
—
18
0
1993
19953
14
5
1960
19910
32
22
1885
19494
35
98
1701
17502
levetiracetam; oral, parenteral
N03AX14 [21604436]
N03AX14 [21604436]
1.4e+00
1.5e+00
1.7e+00
—
2.5e+00
1.5e+00
1.1e+00
cases:1.00%
controls:0.24%
cases:1.04%
controls:0.23%
cases:0.50%
controls:0.09%
—
—
cases:0.56%
controls:0.05%
cases:1.04%
controls:0.25%
cases:1.21%
controls:0.40%
20
48
1983
19847
21
45
1990
19908
10
18
2001
19935
—
11
9
1963
19906
20
48
1897
19468
21
70
1715
17530
Oral Surgery
19 [38004464]
19 [38004464]
8.7e-01
1.3e+00
2.3e+00
1.0e+50
2.8e+00
1.5e+00
8.5e-01
cases:1.55%
controls:0.65%
cases:0.85%
controls:0.23%
cases:0.30%
controls:0.03%
cases:0.75%
controls:0.00%
cases:0.71%
controls:0.05%
cases:0.99%
controls:0.22%
cases:1.56%
controls:0.67%
31
130
1972
19765
17
45
1994
19908
6
6
2005
19947
15
0
1996
19953
14
9
1960
19906
19
42
1898
19474
27
118
1709
17482
Outpatient Hospital
22 [8756]
22 [8756]
3.6e-01
3.8e-01
8.0e-01
5.3e+00
1.6e+00
6.1e-01
4.7e-01
cases:30.85%
controls:23.76%
cases:10.00%
controls:7.05%
cases:1.99%
controls:0.91%
cases:9.35%
controls:0.05%
cases:4.86%
controls:1.02%
cases:11.48%
controls:6.59%
cases:27.25%
controls:18.95%
618
4727
1385
15168
201
1406
1810
18547
40
181
1971
19772
188
10
1823
19943
96
204
1878
19711
220
1286
1697
18230
473
3336
1263
14264
Inpatient Hospital
21 [8717]
21 [8717]
3.9e-01
3.9e-01
7.6e-01
5.0e+00
1.2e+00
4.4e-01
3.4e-01
cases:40.94%
controls:32.04%
cases:14.67%
controls:10.42%
cases:3.13%
controls:1.49%
cases:9.70%
controls:0.07%
cases:4.91%
controls:1.60%
cases:14.66%
controls:9.98%
cases:32.78%
controls:25.76%
820
6374
1183
13521
295
2079
1716
17874
63
297
1948
19656
195
14
1816
19939
97
318
1877
19597
281
1948
1636
17568
569
4533
1167
13067
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
6.7e-01
5.3e-01
1.2e+00
3.6e+00
1.2e+00
6.6e-01
5.1e-01
cases:10.83%
controls:5.88%
cases:3.68%
controls:2.21%
cases:0.94%
controls:0.29%
cases:1.09%
controls:0.03%
cases:1.22%
controls:0.35%
cases:4.54%
controls:2.40%
cases:11.46%
controls:7.20%
217
1170
1786
18725
74
440
1937
19513
19
57
1992
19896
22
6
1989
19947
24
70
1950
19845
87
468
1830
19048
199
1268
1537
16332
General Surgery
2 [38004447]
2 [38004447]
3.5e-01
3.8e-01
8.1e-01
4.9e+00
1.0e+00
4.8e-01
4.3e-01
cases:22.77%
controls:17.24%
cases:7.96%
controls:5.56%
cases:1.79%
controls:0.80%
cases:5.22%
controls:0.04%
cases:2.03%
controls:0.75%
cases:8.61%
controls:5.52%
cases:21.54%
controls:15.16%
456
3429
1547
16466
160
1109
1851
18844
36
160
1975
19793
105
8
1906
19945
40
150
1934
19765
165
1078
1752
18438
374
2668
1362
14932
Otolaryngology
4 [38004449]
4 [38004449]
4.9e-01
7.2e-01
1.7e+00
—
3.2e+00
1.2e+00
7.1e-01
cases:15.98%
controls:10.39%
cases:7.51%
controls:3.82%
cases:2.78%
controls:0.54%
—
—
cases:13.37%
controls:0.60%
cases:11.58%
controls:3.83%
cases:19.76%
controls:10.80%
320
2068
1683
17827
151
762
1860
19191
56
107
1955
19846
—
264
120
1710
19795
222
748
1695
18768
343
1900
1393
15700
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
4.9e-01
9.0e-01
1.8e+00
—
2.3e+00
1.1e+00
6.8e-01
cases:5.29%
controls:3.30%
cases:2.39%
controls:0.98%
cases:0.35%
controls:0.06%
—
—
cases:0.76%
controls:0.08%
cases:2.66%
controls:0.91%
cases:6.57%
controls:3.43%
106
656
1897
19239
48
196
1963
19757
7
12
2004
19941
—
15
16
1959
19899
51
177
1866
19339
114
603
1622
16997
Psychiatry
26 [38004469]
26 [38004469]
6.4e-01
9.3e-01
9.5e-01
1.9e+00
1.1e+00
9.8e-01
6.4e-01
cases:8.49%
controls:4.68%
cases:5.57%
controls:2.28%
cases:2.04%
controls:0.80%
cases:0.45%
controls:0.07%
cases:2.43%
controls:0.81%
cases:5.89%
controls:2.30%
cases:8.99%
controls:4.97%
170
932
1833
18963
112
455
1899
19498
41
159
1970
19794
9
13
2002
19940
48
162
1926
19753
113
449
1804
19067
156
874
1580
16726
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
2.0e-01
6.0e-01
1.0e+00
4.4e+00
1.1e+00
2.5e-01
1.9e-01
cases:9.24%
controls:7.70%
cases:6.71%
controls:3.79%
cases:1.39%
controls:0.51%
cases:2.29%
controls:0.03%
cases:1.62%
controls:0.56%
cases:5.11%
controls:4.03%
cases:13.25%
controls:11.25%
185
1532
1818
18363
135
757
1876
19196
28
102
1983
19851
46
6
1965
19947
32
111
1942
19804
98
787
1819
18729
230
1980
1506
15620
Internal Medicine
11 [38004456]
11 [38004456]
4.0e-01
3.4e-01
6.8e-01
4.2e+00
6.3e-01
3.1e-01
2.9e-01
cases:26.36%
controls:19.30%
cases:11.59%
controls:8.57%
cases:3.03%
controls:1.56%
cases:2.78%
controls:0.05%
cases:2.63%
controls:1.43%
cases:10.95%
controls:8.30%
cases:24.65%
controls:19.65%
528
3839
1475
16056
233
1709
1778
18244
61
312
1950
19641
56
9
1955
19944
52
284
1922
19631
210
1619
1707
17897
428
3458
1308
14142
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
5.6e-01
8.2e-01
1.5e+00
—
2.8e+00
1.3e+00
9.9e-01
cases:2.80%
controls:1.62%
cases:1.14%
controls:0.51%
cases:0.30%
controls:0.07%
—
—
cases:1.37%
controls:0.08%
cases:1.83%
controls:0.48%
cases:4.95%
controls:1.90%
56
322
1947
19573
23
101
1988
19852
6
13
2005
19940
—
27
16
1947
19899
35
94
1882
19422
86
334
1650
17266
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
7.2e-01
8.8e-01
2.2e+00
—
2.2e+00
5.5e-01
5.3e-01
cases:2.50%
controls:1.23%
cases:1.69%
controls:0.71%
cases:0.75%
controls:0.09%
—
—
cases:0.61%
controls:0.07%
cases:1.15%
controls:0.67%
cases:4.09%
controls:2.44%
50
245
1953
19650
34
142
1977
19811
15
17
1996
19936
—
12
13
1962
19902
22
130
1895
19386
71
429
1665
17171
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
6.3e-01
1.1e+00
2.2e+00
—
2.0e+00
1.6e-01
5.6e-01
cases:4.09%
controls:2.23%
cases:2.49%
controls:0.87%
cases:1.14%
controls:0.13%
—
—
cases:0.81%
controls:0.11%
cases:1.10%
controls:0.94%
cases:5.01%
controls:2.93%
82
443
1921
19452
50
174
1961
19779
23
25
1988
19928
—
16
21
1958
19894
21
183
1896
19333
87
516
1649
17084
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
5.8e-01
8.7e-01
1.3e+00
—
1.6e+00
1.2e+00
9.1e-01
cases:6.59%
controls:3.78%
cases:2.83%
controls:1.21%
cases:0.65%
controls:0.17%
—
—
cases:0.86%
controls:0.17%
cases:3.29%
controls:1.06%
cases:6.68%
controls:2.80%
132
753
1871
19142
57
242
1954
19711
13
34
1998
19919
—
17
34
1957
19881
63
206
1854
19310
116
493
1620
17107
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
3.8e-01
4.3e-01
8.6e-01
2.8e+00
1.1e+00
4.1e-01
4.6e-01
cases:8.94%
controls:6.27%
cases:5.27%
controls:3.50%
cases:1.44%
controls:0.62%
cases:0.50%
controls:0.03%
cases:1.67%
controls:0.59%
cases:4.96%
controls:3.35%
cases:13.25%
controls:8.81%
179
1247
1824
18648
106
698
1905
19255
29
123
1982
19830
10
6
2001
19947
33
117
1941
19798
95
653
1822
18863
230
1550
1506
16050
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.6e-01
3.8e-01
6.7e-01
3.6e+00
1.2e+00
2.8e-01
2.7e-01
cases:20.87%
controls:18.38%
cases:16.76%
controls:12.10%
cases:4.67%
controls:2.45%
cases:6.02%
controls:0.17%
cases:6.89%
controls:2.24%
cases:15.75%
controls:12.38%
cases:32.20%
controls:26.59%
418
3656
1585
16239
337
2415
1674
17538
94
489
1917
19464
121
34
1890
19919
136
446
1838
19469
302
2417
1615
17099
559
4679
1177
12921
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
4.7e-01
5.5e-01
7.2e-01
2.5e+00
7.6e-01
5.1e-01
4.6e-01
cases:17.82%
controls:11.91%
cases:10.99%
controls:6.67%
cases:2.69%
controls:1.33%
cases:0.60%
controls:0.05%
cases:3.09%
controls:1.48%
cases:10.95%
controls:6.86%
cases:21.54%
controls:14.77%
357
2369
1646
17526
221
1331
1790
18622
54
265
1957
19688
12
10
1999
19943
61
294
1913
19621
210
1338
1707
18178
374
2600
1362
15000
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
6.9e-01
7.3e-01
2.2e+00
—
3.0e+00
5.7e-01
4.6e-01
cases:1.55%
controls:0.78%
cases:1.09%
controls:0.53%
cases:0.70%
controls:0.08%
—
—
cases:0.51%
controls:0.03%
cases:0.89%
controls:0.50%
cases:2.88%
controls:1.84%
31
155
1972
19740
22
106
1989
19847
14
15
1997
19938
—
10
5
1964
19910
17
98
1900
19418
50
324
1686
17276
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.6e-01
6.6e-01
1.7e+00
—
1.5e+00
7.8e-01
7.4e-01
cases:8.59%
controls:5.58%
cases:4.03%
controls:2.12%
cases:1.14%
controls:0.22%
—
—
cases:0.91%
controls:0.20%
cases:4.02%
controls:1.89%
cases:11.87%
controls:6.06%
172
1111
1831
18784
81
423
1930
19530
23
43
1988
19910
—
18
39
1956
19876
77
369
1840
19147
206
1066
1530
16534
Outpatient Visit
OP [9202]
OP [9202]
3.7e-01
3.3e-01
4.6e-01
3.0e+00
7.5e-01
4.2e-01
4.7e-01
cases:70.84%
controls:62.64%
cases:51.67%
controls:43.47%
cases:14.47%
controls:9.69%
cases:9.15%
controls:0.49%
cases:18.39%
controls:9.61%
cases:54.51%
controls:43.99%
cases:80.53%
controls:72.12%
1419
12463
584
7432
1039
8673
972
11280
291
1933
1720
18020
184
98
1827
19855
363
1913
1611
18002
1045
8586
872
10930
1398
12693
338
4907
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
4.7e-01
1.0e+00
2.1e+00
—
2.6e+00
5.2e-01
3.4e-01
cases:1.15%
controls:0.72%
cases:0.90%
controls:0.32%
cases:0.30%
controls:0.04%
—
—
cases:0.61%
controls:0.05%
cases:0.63%
controls:0.37%
cases:1.73%
controls:1.24%
23
143
1980
19752
18
64
1993
19889
6
7
2005
19946
—
12
9
1962
19906
12
73
1905
19443
30
218
1706
17382
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
6.3e-01
1.1e+00
1.9e+00
—
2.6e+00
—
-2.6e-01
cases:0.80%
controls:0.43%
cases:0.65%
controls:0.21%
cases:0.40%
controls:0.06%
—
—
cases:0.46%
controls:0.04%
—
—
cases:0.98%
controls:1.27%
16
85
1987
19810
13
42
1998
19911
8
12
2003
19941
—
9
7
1965
19908
—
17
223
1719
17377
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
5.0e-01
9.2e-01
2.0e+00
—
2.7e+00
7.2e-01
3.7e-01
cases:1.55%
controls:0.94%
cases:1.09%
controls:0.44%
cases:0.30%
controls:0.04%
—
—
cases:0.71%
controls:0.05%
cases:0.89%
controls:0.44%
cases:2.25%
controls:1.56%
31
187
1972
19708
22
88
1989
19865
6
8
2005
19945
—
14
10
1960
19905
17
85
1900
19431
39
274
1697
17326
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.4e-01
2.4e-01
5.1e-01
3.6e+00
9.7e-01
2.7e-01
1.5e-01
cases:22.57%
controls:20.14%
cases:18.85%
controls:15.44%
cases:4.87%
controls:3.00%
cases:5.72%
controls:0.17%
cases:7.19%
controls:2.85%
cases:20.03%
controls:16.04%
cases:32.83%
controls:29.54%
452
4007
1551
15888
379
3080
1632
16873
98
598
1913
19355
115
34
1896
19919
142
567
1832
19348
384
3130
1533
16386
570
5199
1166
12401
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
4.5e-01
8.4e-01
2.0e+00
—
2.7e+00
7.3e-01
4.0e-01
cases:1.45%
controls:0.93%
cases:0.99%
controls:0.43%
cases:0.30%
controls:0.04%
—
—
cases:0.71%
controls:0.05%
cases:0.89%
controls:0.43%
cases:2.25%
controls:1.52%
29
185
1974
19710
20
86
1991
19867
6
8
2005
19945
—
14
10
1960
19905
17
84
1900
19432
39
267
1697
17333
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
5.3e-01
9.3e-01
2.0e+00
—
2.6e+00
6.0e-01
3.8e-01
cases:1.55%
controls:0.92%
cases:1.09%
controls:0.44%
cases:0.30%
controls:0.04%
—
—
cases:0.71%
controls:0.06%
cases:0.78%
controls:0.43%
cases:2.25%
controls:1.54%
31
183
1972
19712
22
87
1989
19866
6
8
2005
19945
—
14
11
1960
19904
15
84
1902
19432
39
271
1697
17329
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.4e-01
2.4e-01
4.9e-01
3.5e+00
9.7e-01
2.6e-01
1.6e-01
cases:22.67%
controls:20.24%
cases:19.14%
controls:15.65%
cases:4.92%
controls:3.08%
cases:5.67%
controls:0.18%
cases:7.29%
controls:2.89%
cases:20.14%
controls:16.22%
cases:33.18%
controls:29.70%
454
4026
1549
15869
385
3122
1626
16831
99
614
1912
19339
114
36
1897
19917
144
575
1830
19340
386
3166
1531
16350
576
5227
1160
12373
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
9.8e-01
9.3e-01
1.5e+00
—
9.3e-01
1.1e+00
8.7e-01
cases:1.85%
controls:0.70%
cases:1.39%
controls:0.55%
cases:0.80%
controls:0.18%
—
—
cases:0.51%
controls:0.20%
cases:1.62%
controls:0.52%
cases:2.07%
controls:0.88%
37
139
1966
19756
28
110
1983
19843
16
35
1995
19918
—
10
40
1964
19875
31
102
1886
19414
36
155
1700
17445
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
9.9e-01
1.1e+00
2.4e+00
—
1.6e+00
4.6e-01
7.3e-01
cases:2.95%
controls:1.11%
cases:1.44%
controls:0.50%
cases:0.75%
controls:0.07%
—
—
cases:0.35%
controls:0.08%
cases:0.99%
controls:0.63%
cases:3.28%
controls:1.61%
59
221
1944
19674
29
100
1982
19853
15
14
1996
19939
—
7
15
1967
19900
19
122
1898
19394
57
284
1679
17316
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
5.2e-01
7.1e-01
1.3e+00
—
2.1e+00
4.6e-01
4.9e-01
cases:10.28%
controls:6.36%
cases:3.98%
controls:1.99%
cases:0.80%
controls:0.22%
—
—
cases:1.62%
controls:0.20%
cases:3.18%
controls:2.03%
cases:11.92%
controls:7.69%
206
1266
1797
18629
80
397
1931
19556
16
44
1995
19909
—
32
39
1942
19876
61
397
1856
19119
207
1353
1529
16247
General Practice
1 [38004446]
1 [38004446]
5.3e-01
7.5e-01
1.4e+00
—
1.5e+00
4.1e-01
4.1e-01
cases:15.78%
controls:9.89%
cases:7.66%
controls:3.76%
cases:2.34%
controls:0.60%
—
—
cases:2.84%
controls:0.62%
cases:6.10%
controls:4.12%
cases:16.71%
controls:11.79%
316
1968
1687
17927
154
751
1857
19202
47
119
1964
19834
—
56
123
1918
19792
117
804
1800
18712
290
2075
1446
15525
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.3e-01
3.7e-01
4.2e-01
3.2e+00
8.0e-01
3.4e-01
3.4e-01
cases:8.29%
controls:6.09%
cases:5.07%
controls:3.57%
cases:1.79%
controls:1.18%
cases:1.79%
controls:0.08%
cases:2.63%
controls:1.21%
cases:5.01%
controls:3.63%
cases:10.60%
controls:7.79%
166
1212
1837
18683
102
713
1909
19240
36
235
1975
19718
36
15
1975
19938
52
240
1922
19675
96
709
1821
18807
184
1371
1552
16229
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.2e-01
2.2e-01
4.8e-01
3.3e+00
8.3e-01
2.2e-01
1.2e-01
cases:23.96%
controls:21.91%
cases:21.23%
controls:17.85%
cases:5.97%
controls:3.77%
cases:5.67%
controls:0.23%
cases:7.80%
controls:3.57%
cases:22.33%
controls:18.74%
cases:35.31%
controls:32.52%
480
4359
1523
15536
427
3562
1584
16391
120
753
1891
19200
114
46
1897
19907
154
711
1820
19204
428
3658
1489
15858
613
5723
1123
11877
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
5.9e-01
6.7e-01
2.1e+00
—
2.9e+00
6.3e-01
4.6e-01
cases:1.45%
controls:0.81%
cases:1.04%
controls:0.54%
cases:0.60%
controls:0.08%
—
—
cases:0.46%
controls:0.03%
cases:0.89%
controls:0.48%
cases:2.82%
controls:1.80%
29
161
1974
19734
21
107
1990
19846
12
15
1999
19938
—
9
5
1965
19910
17
93
1900
19423
49
317
1687
17283
trimipramine; oral, parenteral
N06AA06 [21604693]
N06AA06 [21604693]
1.5e+00
1.7e+00
—
—
—
1.8e+00
9.3e-01
cases:0.65%
controls:0.15%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.37%
controls:0.06%
cases:0.35%
controls:0.14%
13
30
1990
19865
9
16
2002
19937
—
—
—
7
12
1910
19504
6
24
1730
17576
risperidone; oral, parenteral
N05AX08 [21604559]
N05AX08 [21604559]
1.0e+00
1.2e+00
1.2e+00
1.0e+50
1.6e+00
1.1e+00
2.1e-01
cases:2.05%
controls:0.76%
cases:1.54%
controls:0.46%
cases:0.45%
controls:0.14%
cases:0.25%
controls:0.00%
cases:0.81%
controls:0.17%
cases:1.67%
controls:0.58%
cases:1.44%
controls:1.17%
41
151
1962
19744
31
92
1980
19861
9
27
2002
19926
5
0
2006
19953
16
33
1958
19882
32
113
1885
19403
25
206
1711
17394
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.0e-01
1.9e-01
6.2e-01
3.2e+00
7.9e-01
1.5e-01
2.2e-01
cases:15.63%
controls:14.32%
cases:14.22%
controls:12.03%
cases:4.43%
controls:2.44%
cases:3.33%
controls:0.14%
cases:5.12%
controls:2.39%
cases:14.40%
controls:12.70%
cases:26.90%
controls:22.73%
313
2848
1690
17047
286
2400
1725
17553
89
487
1922
19466
67
28
1944
19925
101
475
1873
19440
276
2478
1641
17038
467
4000
1269
13600
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.1e-01
1.8e-01
5.4e-01
3.3e+00
9.6e-01
1.7e-01
1.6e-01
cases:22.67%
controls:20.76%
cases:16.31%
controls:13.98%
cases:4.33%
controls:2.56%
cases:3.88%
controls:0.15%
cases:6.13%
controls:2.45%
cases:16.38%
controls:14.13%
cases:32.03%
controls:28.69%
454
4131
1549
15764
328
2790
1683
17163
87
511
1924
19442
78
30
1933
19923
121
488
1853
19427
314
2757
1603
16759
556
5049
1180
12551
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
7.6e-02
2.2e-01
4.4e-01
3.2e+00
8.6e-01
1.6e-01
8.6e-02
cases:25.91%
controls:24.47%
cases:24.12%
controls:20.40%
cases:7.01%
controls:4.64%
cases:6.41%
controls:0.27%
cases:9.57%
controls:4.30%
cases:24.15%
controls:21.29%
cases:38.13%
controls:36.12%
519
4869
1484
15026
485
4071
1526
15882
141
925
1870
19028
129
54
1882
19899
189
857
1785
19058
463
4155
1454
15361
662
6357
1074
11243
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
7.0e-02
2.1e-01
4.4e-01
3.2e+00
8.5e-01
1.6e-01
8.3e-02
cases:25.86%
controls:24.53%
cases:24.07%
controls:20.44%
cases:7.01%
controls:4.63%
cases:6.41%
controls:0.27%
cases:9.52%
controls:4.30%
cases:24.10%
controls:21.31%
cases:38.08%
controls:36.14%
518
4881
1485
15014
484
4078
1527
15875
141
924
1870
19029
129
54
1882
19899
188
857
1786
19058
462
4159
1455
15357
661
6360
1075
11240
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
7.6e-02
2.1e-01
4.3e-01
3.2e+00
8.5e-01
1.6e-01
8.7e-02
cases:25.86%
controls:24.43%
cases:24.02%
controls:20.37%
cases:6.96%
controls:4.64%
cases:6.41%
controls:0.27%
cases:9.52%
controls:4.29%
cases:24.10%
controls:21.24%
cases:38.08%
controls:36.05%
518
4861
1485
15034
483
4065
1528
15888
140
925
1871
19028
129
54
1882
19899
188
855
1786
19060
462
4146
1455
15370
661
6344
1075
11256
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
7.3e-02
2.1e-01
4.3e-01
3.2e+00
8.5e-01
1.6e-01
9.2e-02
cases:25.76%
controls:24.38%
cases:23.97%
controls:20.35%
cases:6.96%
controls:4.64%
cases:6.41%
controls:0.27%
cases:9.52%
controls:4.30%
cases:24.05%
controls:21.23%
cases:38.08%
controls:35.94%
516
4851
1487
15044
482
4060
1529
15893
140
925
1871
19028
129
54
1882
19899
188
857
1786
19058
461
4143
1456
15373
661
6326
1075
11274
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
7.4e-02
2.1e-01
4.3e-01
3.2e+00
8.5e-01
1.6e-01
8.5e-02
cases:25.86%
controls:24.47%
cases:24.07%
controls:20.40%
cases:6.96%
controls:4.64%
cases:6.41%
controls:0.27%
cases:9.52%
controls:4.31%
cases:24.10%
controls:21.27%
cases:38.08%
controls:36.09%
518
4869
1485
15026
484
4071
1527
15882
140
926
1871
19027
129
54
1882
19899
188
858
1786
19057
462
4152
1455
15364
661
6352
1075
11248
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
7.4e-02
2.1e-01
4.3e-01
3.2e+00
8.4e-01
1.6e-01
8.6e-02
cases:25.86%
controls:24.46%
cases:24.02%
controls:20.39%
cases:6.96%
controls:4.64%
cases:6.41%
controls:0.27%
cases:9.47%
controls:4.30%
cases:24.05%
controls:21.25%
cases:38.08%
controls:36.07%
518
4867
1485
15028
483
4068
1528
15885
140
925
1871
19028
129
54
1882
19899
187
857
1787
19058
461
4147
1456
15369
661
6348
1075
11252
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
7.5e-02
2.1e-01
4.3e-01
3.2e+00
8.5e-01
1.6e-01
8.6e-02
cases:25.86%
controls:24.46%
cases:24.07%
controls:20.38%
cases:6.96%
controls:4.64%
cases:6.41%
controls:0.28%
cases:9.52%
controls:4.32%
cases:24.15%
controls:21.28%
cases:38.08%
controls:36.08%
518
4866
1485
15029
484
4066
1527
15887
140
926
1871
19027
129
55
1882
19898
188
860
1786
19055
463
4153
1454
15363
661
6350
1075
11250
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
7.6e-01
8.8e-01
1.5e+00
—
1.1e+00
8.7e-01
7.2e-01
cases:5.24%
controls:2.52%
cases:2.24%
controls:0.94%
cases:0.60%
controls:0.14%
—
—
cases:0.35%
controls:0.12%
cases:1.72%
controls:0.73%
cases:6.11%
controls:3.07%
105
502
1898
19393
45
187
1966
19766
12
28
1999
19925
—
7
23
1967
19892
33
142
1884
19374
106
540
1630
17060
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
4.5e-01
8.3e-01
2.0e+00
—
2.7e+00
7.3e-01
4.0e-01
cases:1.45%
controls:0.93%
cases:0.99%
controls:0.44%
cases:0.30%
controls:0.04%
—
—
cases:0.71%
controls:0.05%
cases:0.89%
controls:0.43%
cases:2.25%
controls:1.52%
29
185
1974
19710
20
87
1991
19866
6
8
2005
19945
—
14
10
1960
19905
17
84
1900
19432
39
268
1697
17332
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
5.1e-01
8.7e-01
2.1e+00
—
2.5e+00
4.2e-01
2.4e-01
cases:1.35%
controls:0.81%
cases:0.85%
controls:0.36%
cases:0.30%
controls:0.04%
—
—
cases:0.61%
controls:0.05%
cases:0.57%
controls:0.38%
cases:1.73%
controls:1.37%
27
162
1976
19733
17
71
1994
19882
6
7
2005
19946
—
12
10
1962
19905
11
74
1906
19442
30
241
1706
17359
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
5.7e-02
1.0e-01
4.5e-01
3.4e+00
8.0e-01
1.9e-01
1.4e-01
cases:16.18%
controls:15.42%
cases:13.67%
controls:12.52%
cases:4.53%
controls:2.95%
cases:4.23%
controls:0.15%
cases:5.52%
controls:2.57%
cases:15.02%
controls:12.80%
cases:26.09%
controls:23.48%
324
3068
1679
16827
275
2499
1736
17454
91
588
1920
19365
85
30
1926
19923
109
511
1865
19404
288
2499
1629
17017
453
4132
1283
13468
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.3e-01
1.1e+00
—
—
-1.0e+50
1.2e+00
1.6e+00
cases:2.60%
controls:1.27%
cases:1.14%
controls:0.38%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.20%
controls:0.36%
cases:3.46%
controls:0.75%
52
252
1951
19643
23
75
1988
19878
—
—
0
12
1974
19903
23
71
1894
19445
60
132
1676
17468
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.3e-01
1.1e+00
—
—
-1.0e+50
1.2e+00
1.6e+00
cases:2.60%
controls:1.27%
cases:1.14%
controls:0.38%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.20%
controls:0.36%
cases:3.46%
controls:0.75%
52
252
1951
19643
23
75
1988
19878
—
—
0
12
1974
19903
23
71
1894
19445
60
132
1676
17468
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.3e-01
1.1e+00
—
—
-1.0e+50
1.2e+00
1.6e+00
cases:2.60%
controls:1.27%
cases:1.14%
controls:0.38%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.20%
controls:0.36%
cases:3.46%
controls:0.75%
52
252
1951
19643
23
75
1988
19878
—
—
0
12
1974
19903
23
71
1894
19445
60
132
1676
17468
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
7.9e-01
1.0e+00
—
—
-1.0e+50
1.3e+00
1.5e+00
cases:2.40%
controls:1.10%
cases:0.90%
controls:0.33%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.10%
controls:0.29%
cases:3.05%
controls:0.72%
48
219
1955
19676
18
66
1993
19887
—
—
0
8
1974
19907
21
56
1896
19460
53
127
1683
17473
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
7.9e-01
1.0e+00
—
—
-1.0e+50
1.3e+00
1.5e+00
cases:2.40%
controls:1.10%
cases:0.90%
controls:0.33%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.10%
controls:0.29%
cases:3.05%
controls:0.72%
48
219
1955
19676
18
66
1993
19887
—
—
0
8
1974
19907
21
56
1896
19460
53
127
1683
17473
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
7.9e-01
1.0e+00
—
—
-1.0e+50
1.3e+00
1.5e+00
cases:2.40%
controls:1.10%
cases:0.90%
controls:0.33%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.10%
controls:0.29%
cases:3.05%
controls:0.72%
48
219
1955
19676
18
66
1993
19887
—
—
0
8
1974
19907
21
56
1896
19460
53
127
1683
17473
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
7.9e-01
1.0e+00
—
—
-1.0e+50
1.3e+00
1.5e+00
cases:2.40%
controls:1.10%
cases:0.90%
controls:0.33%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.10%
controls:0.29%
cases:3.05%
controls:0.72%
48
219
1955
19676
18
66
1993
19887
—
—
0
8
1974
19907
21
56
1896
19460
53
127
1683
17473
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
7.9e-01
1.0e+00
—
—
-1.0e+50
1.3e+00
1.5e+00
cases:2.40%
controls:1.10%
cases:0.90%
controls:0.33%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.10%
controls:0.29%
cases:3.05%
controls:0.72%
48
219
1955
19676
18
66
1993
19887
—
—
0
8
1974
19907
21
56
1896
19460
53
127
1683
17473
Sequelae of cerebral infarction
I69.3 [45533476]
I69.3 [45533476]
8.3e-01
1.2e+00
—
—
1.7e+00
9.0e-01
4.6e-01
cases:1.30%
controls:0.57%
cases:1.04%
controls:0.32%
—
—
—
—
cases:0.46%
controls:0.09%
cases:0.99%
controls:0.40%
cases:1.38%
controls:0.88%
26
114
1977
19781
21
64
1990
19889
—
—
9
17
1965
19898
19
79
1898
19437
24
154
1712
17446
Neurology
13 [38004458]
13 [38004458]
6.0e-01
7.3e-01
9.8e-01
2.0e+00
8.6e-01
7.6e-01
6.0e-01
cases:13.08%
controls:7.63%
cases:6.91%
controls:3.44%
cases:1.64%
controls:0.62%
cases:0.25%
controls:0.04%
cases:1.27%
controls:0.54%
cases:7.20%
controls:3.50%
cases:14.80%
controls:8.73%
262
1517
1741
18378
139
686
1872
19267
33
124
1978
19829
5
7
2006
19946
25
107
1949
19808
138
683
1779
18833
257
1537
1479
16063
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
N05BA06 [21604571]
1.2e+00
1.4e+00
1.2e+00
—
1.1e+00
1.2e+00
7.8e-01
cases:2.00%
controls:0.64%
cases:1.49%
controls:0.37%
cases:0.45%
controls:0.14%
—
—
cases:0.30%
controls:0.11%
cases:1.20%
controls:0.38%
cases:1.67%
controls:0.77%
40
127
1963
19768
30
73
1981
19880
9
27
2002
19926
—
6
21
1968
19894
23
74
1894
19442
29
136
1707
17464
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
4.9e-01
5.2e-01
1.2e+00
—
1.4e+00
8.6e-01
5.8e-01
cases:5.19%
controls:3.23%
cases:1.94%
controls:1.16%
cases:0.65%
controls:0.20%
—
—
cases:0.71%
controls:0.18%
cases:2.66%
controls:1.15%
cases:6.11%
controls:3.52%
104
643
1899
19252
39
232
1972
19721
13
40
1998
19913
—
14
36
1960
19879
51
224
1866
19292
106
619
1630
16981
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
1.1e-01
1.9e-01
4.2e-01
3.2e+00
8.1e-01
2.0e-01
1.8e-02
cases:19.97%
controls:18.30%
cases:16.61%
controls:14.17%
cases:4.72%
controls:3.16%
cases:4.62%
controls:0.20%
cases:6.33%
controls:2.91%
cases:17.11%
controls:14.48%
cases:27.82%
controls:27.47%
400
3640
1603
16255
334
2827
1677
17126
95
630
1916
19323
93
39
1918
19914
125
579
1849
19336
328
2825
1589
16691
483
4834
1253
12766
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
7.1e-01
5.6e-01
3.1e-01
1.3e+00
3.4e-01
5.0e-01
7.5e-01
cases:96.36%
controls:92.88%
cases:87.32%
controls:79.78%
cases:47.09%
controls:39.52%
cases:6.41%
controls:1.88%
cases:48.38%
controls:40.06%
cases:87.12%
controls:80.42%
cases:97.06%
controls:93.95%
1930
18479
73
1416
1756
15918
255
4035
947
7885
1064
12068
129
376
1882
19577
955
7977
1019
11938
1670
15694
247
3822
1685
16536
51
1064
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.9e-01
5.4e-01
6.9e-01
—
1.7e+00
9.2e-01
7.0e-01
cases:9.84%
controls:5.70%
cases:2.83%
controls:1.68%
cases:0.35%
controls:0.18%
—
—
cases:0.86%
controls:0.17%
cases:3.60%
controls:1.47%
cases:8.24%
controls:4.27%
197
1134
1806
18761
57
335
1954
19618
7
35
2004
19918
—
17
33
1957
19882
69
286
1848
19230
143
751
1593
16849
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
5.8e-02
1.3e-01
4.8e-01
3.5e+00
4.6e-01
1.4e-01
7.8e-02
cases:48.43%
controls:46.98%
cases:43.66%
controls:40.46%
cases:23.17%
controls:15.77%
cases:24.17%
controls:1.00%
cases:22.59%
controls:15.58%
cases:45.44%
controls:42.10%
cases:61.46%
controls:59.60%
970
9347
1033
10548
878
8072
1133
11881
466
3147
1545
16806
486
199
1525
19754
446
3102
1528
16813
871
8217
1046
11299
1067
10490
669
7110
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
5.7e-01
8.8e-01
1.7e+00
—
1.3e+00
6.3e-01
5.8e-01
cases:4.84%
controls:2.81%
cases:2.29%
controls:0.96%
cases:0.45%
controls:0.08%
—
—
cases:0.41%
controls:0.11%
cases:1.93%
controls:1.04%
cases:6.80%
controls:3.94%
97
559
1906
19336
46
192
1965
19761
9
16
2002
19937
—
8
22
1966
19893
37
202
1880
19314
118
693
1618
16907
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
R03DA04 [21603332]
1.2e+00
1.1e+00
1.1e+00
—
1.4e+00
9.5e-01
1.0e+00
cases:1.85%
controls:0.54%
cases:1.09%
controls:0.36%
cases:0.25%
controls:0.09%
—
—
cases:0.30%
controls:0.08%
cases:0.89%
controls:0.34%
cases:1.21%
controls:0.44%
37
108
1966
19787
22
72
1989
19881
5
17
2006
19936
—
6
15
1968
19900
17
67
1900
19449
21
78
1715
17522
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
4.1e-01
5.2e-01
1.1e+00
1.0e+50
1.2e+00
4.7e-01
5.1e-01
cases:31.55%
controls:23.39%
cases:11.44%
controls:7.14%
cases:1.94%
controls:0.65%
cases:0.50%
controls:0.00%
cases:2.13%
controls:0.64%
cases:10.75%
controls:7.00%
cases:30.82%
controls:21.11%
632
4654
1371
15241
230
1425
1781
18528
39
130
1972
19823
10
0
2001
19953
42
127
1932
19788
206
1367
1711
18149
535
3715
1201
13885
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
4.4e-01
1.2e+00
2.3e+00
—
3.0e+00
1.6e-01
1.9e-01
cases:0.90%
controls:0.58%
cases:0.85%
controls:0.26%
cases:0.25%
controls:0.03%
—
—
cases:0.61%
controls:0.03%
cases:0.31%
controls:0.27%
cases:1.09%
controls:0.90%
18
115
1985
19780
17
51
1994
19902
5
5
2006
19948
—
12
6
1962
19909
6
52
1911
19464
19
159
1717
17441
Chronic maxillary sinusitis
J32.0 [45586667]
J32.0 [45586667]
8.7e-01
1.1e+00
—
—
—
1.3e+00
9.7e-01
cases:1.40%
controls:0.59%
cases:0.75%
controls:0.25%
—
—
—
—
—
—
cases:0.83%
controls:0.24%
cases:1.73%
controls:0.66%
28
118
1975
19777
15
50
1996
19903
—
—
—
16
46
1901
19470
30
116
1706
17484
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
2.3e-01
3.5e-01
4.9e-01
2.1e+00
7.9e-01
3.0e-01
3.8e-01
cases:14.03%
controls:11.49%
cases:10.04%
controls:7.29%
cases:2.24%
controls:1.39%
cases:0.60%
controls:0.07%
cases:2.74%
controls:1.27%
cases:9.49%
controls:7.22%
cases:22.06%
controls:16.20%
281
2285
1722
17610
202
1454
1809
18499
45
277
1966
19676
12
14
1999
19939
54
252
1920
19663
182
1409
1735
18107
383
2852
1353
14748
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
4.7e-01
7.7e-01
1.4e+00
—
1.5e+00
4.1e-01
3.3e-01
cases:4.19%
controls:2.65%
cases:2.83%
controls:1.33%
cases:0.75%
controls:0.19%
—
—
cases:0.81%
controls:0.18%
cases:1.77%
controls:1.19%
cases:5.53%
controls:4.05%
84
528
1919
19367
57
265
1954
19688
15
37
1996
19916
—
16
36
1958
19879
34
232
1883
19284
96
713
1640
16887
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
1.5e+00
8.1e-01
2.7e+00
—
—
6.6e-01
4.1e-01
cases:0.75%
controls:0.18%
cases:0.35%
controls:0.16%
cases:0.50%
controls:0.04%
—
—
—
—
cases:0.42%
controls:0.22%
cases:1.32%
controls:0.88%
15
35
1988
19860
7
31
2004
19922
10
7
2001
19946
—
—
8
42
1909
19474
23
155
1713
17445
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
5.1e-01
1.8e-01
—
—
1.8e+00
1.1e+00
7.3e-01
cases:4.89%
controls:3.00%
cases:1.09%
controls:0.92%
—
—
—
—
cases:0.51%
controls:0.09%
cases:2.09%
controls:0.72%
cases:4.26%
controls:2.11%
98
597
1905
19298
22
183
1989
19770
—
—
10
17
1964
19898
40
140
1877
19376
74
371
1662
17229
Tension-type headache
G44.2 [45581495]
G44.2 [45581495]
8.2e-01
1.0e+00
—
—
—
1.3e+00
9.9e-01
cases:2.35%
controls:1.05%
cases:0.75%
controls:0.27%
—
—
—
—
—
—
cases:1.25%
controls:0.36%
cases:3.57%
controls:1.36%
47
208
1956
19687
15
54
1996
19899
—
—
—
24
70
1893
19446
62
239
1674
17361
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
4.2e-01
6.2e-01
—
—
2.4e+00
9.9e-01
6.7e-01
cases:1.70%
controls:1.13%
cases:0.70%
controls:0.38%
—
—
—
—
cases:0.66%
controls:0.06%
cases:1.10%
controls:0.41%
cases:2.88%
controls:1.49%
34
224
1969
19671
14
75
1997
19878
—
—
13
12
1961
19903
21
80
1896
19436
50
262
1686
17338
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
4.6e-01
3.4e-01
5.4e-02
—
2.1e+00
7.0e-01
7.1e-01
cases:8.89%
controls:5.81%
cases:2.39%
controls:1.71%
cases:0.25%
controls:0.24%
—
—
cases:1.62%
controls:0.20%
cases:2.82%
controls:1.41%
cases:8.99%
controls:4.63%
178
1156
1825
18739
48
341
1963
19612
5
47
2006
19906
—
32
39
1942
19876
54
276
1863
19240
156
815
1580
16785
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
3.7e-01
6.1e-01
1.0e+00
—
1.1e+00
5.0e-01
3.6e-01
cases:6.29%
controls:4.41%
cases:3.78%
controls:2.09%
cases:0.70%
controls:0.25%
—
—
cases:0.91%
controls:0.30%
cases:3.29%
controls:2.03%
cases:9.04%
controls:6.48%
126
878
1877
19017
76
418
1935
19535
14
50
1997
19903
—
18
59
1956
19856
63
396
1854
19120
157
1140
1579
16460
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
9.3e-01
1.2e+00
—
—
—
1.8e+00
2.1e-01
cases:1.25%
controls:0.50%
cases:0.65%
controls:0.19%
—
—
—
—
—
—
cases:0.78%
controls:0.13%
cases:0.69%
controls:0.56%
25
99
1978
19796
13
38
1998
19915
—
—
—
15
25
1902
19491
12
99
1724
17501
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
3.3e-01
5.8e-01
9.6e-01
—
1.2e+00
3.8e-01
4.8e-01
cases:34.85%
controls:27.76%
cases:14.12%
controls:8.42%
cases:2.39%
controls:0.93%
—
—
cases:3.24%
controls:1.01%
cases:12.15%
controls:8.62%
cases:37.50%
controls:27.14%
698
5523
1305
14372
284
1681
1727
18272
48
185
1963
19768
—
64
202
1910
19713
233
1683
1684
17833
651
4777
1085
12823
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-9.3e-01
-5.9e-01
-9.4e-01
—
1.6e+00
2.3e+00
3.1e+00
cases:11.78%
controls:25.38%
cases:4.23%
controls:7.38%
cases:0.35%
controls:0.88%
—
—
cases:0.30%
controls:0.06%
cases:3.55%
controls:0.36%
cases:14.40%
controls:0.75%
236
5049
1767
14846
85
1473
1926
18480
7
176
2004
19777
—
6
12
1968
19903
68
71
1849
19445
250
132
1486
17468
Rhinopharyngoscopy
UDH02 [2001301680]
UDH02 [2001301680]
8.2e-01
9.1e-01
—
—
—
1.9e+00
1.1e+00
cases:1.10%
controls:0.49%
cases:0.40%
controls:0.16%
—
—
—
—
—
—
cases:0.89%
controls:0.13%
cases:1.27%
controls:0.44%
22
97
1981
19798
8
32
2003
19921
—
—
—
17
25
1900
19491
22
78
1714
17522
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
4.7e-01
7.6e-01
1.2e+00
—
1.4e+00
3.4e-01
3.0e-01
cases:4.49%
controls:2.87%
cases:3.38%
controls:1.61%
cases:0.85%
controls:0.25%
—
—
cases:0.96%
controls:0.25%
cases:2.71%
controls:1.94%
cases:7.72%
controls:5.85%
90
571
1913
19324
68
321
1943
19632
17
49
1994
19904
—
19
50
1955
19865
52
379
1865
19137
134
1029
1602
16571
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
8.6e-01
9.6e-01
8.1e-01
—
—
1.0e+00
9.1e-01
cases:1.25%
controls:0.53%
cases:0.80%
controls:0.31%
cases:0.25%
controls:0.11%
—
—
—
—
cases:0.89%
controls:0.31%
cases:1.61%
controls:0.65%
25
106
1978
19789
16
61
1995
19892
5
22
2006
19931
—
—
17
61
1900
19455
28
115
1708
17485
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
5.7e-01
8.3e-01
9.1e-01
—
1.9e+00
2.9e-01
5.2e-01
cases:5.19%
controls:2.99%
cases:1.84%
controls:0.81%
cases:0.25%
controls:0.10%
—
—
cases:0.61%
controls:0.10%
cases:1.20%
controls:0.90%
cases:5.24%
controls:3.20%
104
595
1899
19300
37
162
1974
19791
5
20
2006
19933
—
12
19
1962
19896
23
176
1894
19340
91
563
1645
17037
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
8.0e-02
4.4e-03
4.7e-01
3.8e+00
3.8e-01
2.2e-02
6.9e-02
cases:12.58%
controls:11.73%
cases:5.87%
controls:5.84%
cases:1.69%
controls:1.06%
cases:1.49%
controls:0.04%
cases:1.57%
controls:1.07%
cases:6.47%
controls:6.34%
cases:16.65%
controls:15.72%
252
2333
1751
17562
118
1166
1893
18787
34
212
1977
19741
30
7
1981
19946
31
214
1943
19701
124
1237
1793
18279
289
2766
1447
14834
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
4.8e-02
1.3e-01
4.0e-01
2.8e+00
6.1e-01
1.5e-01
4.5e-02
cases:28.36%
controls:27.39%
cases:28.39%
controls:25.90%
cases:11.74%
controls:8.20%
cases:7.51%
controls:0.52%
cases:13.58%
controls:7.83%
cases:30.26%
controls:27.10%
cases:41.24%
controls:40.15%
568
5449
1435
14446
571
5168
1440
14785
236
1637
1775
18316
151
103
1860
19850
268
1559
1706
18356
580
5289
1337
14227
716
7067
1020
10533
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
4.6e-01
4.2e-01
1.1e+00
1.0e+50
2.7e+00
4.2e-01
4.4e-01
cases:5.84%
controls:3.77%
cases:1.39%
controls:0.92%
cases:0.30%
controls:0.10%
cases:4.82%
controls:0.00%
cases:1.57%
controls:0.11%
cases:1.30%
controls:0.86%
cases:4.90%
controls:3.20%
117
751
1886
19144
28
183
1983
19770
6
20
2005
19933
97
0
1914
19953
31
22
1943
19893
25
168
1892
19348
85
564
1651
17036
montelukast; oral
R03DC03 [21603356]
R03DC03 [21603356]
7.6e-01
5.8e-01
5.4e-01
—
9.2e-01
5.7e-01
7.3e-01
cases:4.19%
controls:2.02%
cases:2.34%
controls:1.32%
cases:0.50%
controls:0.29%
—
—
cases:0.96%
controls:0.39%
cases:2.35%
controls:1.34%
cases:5.88%
controls:2.91%
84
401
1919
19494
47
264
1964
19689
10
58
2001
19895
—
19
77
1955
19838
45
261
1872
19255
102
513
1634
17087
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
1.2e-01
2.0e-01
5.0e-01
2.9e+00
2.3e-01
3.0e-01
3.5e-01
cases:19.62%
controls:17.73%
cases:9.50%
controls:7.92%
cases:2.09%
controls:1.27%
cases:0.99%
controls:0.06%
cases:1.62%
controls:1.30%
cases:9.75%
controls:7.40%
cases:22.24%
controls:16.84%
393
3528
1610
16367
191
1581
1820
18372
42
254
1969
19699
20
11
1991
19942
32
258
1942
19657
187
1444
1730
18072
386
2963
1350
14637
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
FB1BD [2001302407]
9.5e-01
1.5e+00
—
—
—
6.4e-01
1.1e+00
cases:1.15%
controls:0.45%
cases:0.65%
controls:0.15%
—
—
—
—
—
—
cases:0.26%
controls:0.14%
cases:1.04%
controls:0.36%
23
89
1980
19806
13
29
1998
19924
—
—
—
5
27
1912
19489
18
64
1718
17536
Status asthmaticus
J46 [45591560]
J46 [45591560]
1.6e+00
1.7e+00
—
—
—
1.9e+00
2.4e-01
cases:0.75%
controls:0.15%
cases:0.30%
controls:0.06%
—
—
—
—
—
—
cases:0.37%
controls:0.06%
cases:0.35%
controls:0.27%
15
30
1988
19865
6
11
2005
19942
—
—
—
7
11
1910
19505
6
48
1730
17552
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
F33.10 [2000501984]
5.3e-01
1.2e+00
—
—
—
1.3e+00
1.0e+00
cases:0.85%
controls:0.50%
cases:0.75%
controls:0.24%
—
—
—
—
—
—
cases:0.68%
controls:0.19%
cases:1.32%
controls:0.47%
17
100
1986
19795
15
47
1996
19906
—
—
—
13
37
1904
19479
23
83
1713
17517
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
3.6e-02
3.2e-01
4.8e-01
2.5e+00
6.4e-01
4.8e-01
4.9e-01
cases:3.79%
controls:3.66%
cases:2.78%
controls:2.03%
cases:0.75%
controls:0.46%
cases:0.30%
controls:0.03%
cases:0.71%
controls:0.38%
cases:3.18%
controls:1.99%
cases:6.68%
controls:4.22%
76
729
1927
19166
56
405
1955
19548
15
92
1996
19861
6
5
2005
19948
14
75
1960
19840
61
389
1856
19127
116
742
1620
16858
Myalgia
M79.1 [45587062]
M79.1 [45587062]
7.1e-01
3.9e-01
2.0e+00
—
—
6.7e-01
6.5e-01
cases:2.00%
controls:0.99%
cases:0.55%
controls:0.37%
cases:0.30%
controls:0.04%
—
—
—
—
cases:0.89%
controls:0.46%
cases:2.88%
controls:1.52%
40
197
1963
19698
11
74
2000
19879
6
8
2005
19945
—
—
17
89
1900
19427
50
268
1686
17332
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
4.7e-01
7.3e-01
1.0e+00
—
7.5e-01
6.8e-01
4.7e-01
cases:5.24%
controls:3.33%
cases:3.33%
controls:1.64%
cases:1.09%
controls:0.41%
—
—
cases:0.96%
controls:0.46%
cases:3.34%
controls:1.73%
cases:5.18%
controls:3.30%
105
663
1898
19232
67
327
1944
19626
22
81
1989
19872
—
19
91
1955
19824
64
337
1853
19179
90
581
1646
17019
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
4.7e-01
7.8e-01
—
—
1.7e+00
1.2e+00
9.1e-01
cases:3.44%
controls:2.19%
cases:1.34%
controls:0.62%
—
—
—
—
cases:0.35%
controls:0.07%
cases:1.56%
controls:0.48%
cases:3.86%
controls:1.60%
69
436
1934
19459
27
124
1984
19829
—
—
7
13
1967
19902
30
94
1887
19422
67
281
1669
17319
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
4.0e-01
5.3e-01
3.7e-01
—
1.0e+00
7.4e-01
6.5e-01
cases:9.44%
controls:6.53%
cases:5.62%
controls:3.37%
cases:1.09%
controls:0.76%
—
—
cases:2.23%
controls:0.83%
cases:6.89%
controls:3.42%
cases:14.52%
controls:8.17%
189
1299
1814
18596
113
673
1898
19280
22
151
1989
19802
—
44
165
1930
19750
132
668
1785
18848
252
1438
1484
16162
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-2.6e-03
5.5e-02
5.2e-01
2.9e+00
5.6e-01
1.9e-01
3.6e-01
cases:5.84%
controls:5.86%
cases:4.77%
controls:4.53%
cases:1.89%
controls:1.13%
cases:0.94%
controls:0.05%
cases:1.62%
controls:0.93%
cases:5.69%
controls:4.76%
cases:12.10%
controls:8.78%
117
1165
1886
18730
96
904
1915
19049
38
226
1973
19727
19
10
1992
19943
32
186
1942
19729
109
928
1808
18588
210
1546
1526
16054
Pediatric Medicine
37 [38004477]
37 [38004477]
-1.7e-01
-3.3e-01
-2.8e-01
3.3e+00
4.7e-02
-3.7e-01
-1.6e-02
cases:3.99%
controls:4.69%
cases:2.09%
controls:2.89%
cases:0.60%
controls:0.79%
cases:0.94%
controls:0.04%
cases:0.81%
controls:0.77%
cases:1.77%
controls:2.56%
cases:3.46%
controls:3.51%
80
934
1923
18961
42
577
1969
19376
12
157
1999
19796
19
7
1992
19946
16
154
1958
19761
34
499
1883
19017
60
618
1676
16982
Other chest pain
R07.3 [45597166]
R07.3 [45597166]
4.9e-01
1.2e+00
—
—
—
1.4e+00
6.6e-01
cases:1.10%
controls:0.68%
cases:0.75%
controls:0.22%
—
—
—
—
—
—
cases:0.68%
controls:0.17%
cases:1.84%
controls:0.96%
22
135
1981
19760
15
44
1996
19909
—
—
—
13
34
1904
19482
32
169
1704
17431
Throat symptom/complaint
R21 [2002000891]
R21 [2002000891]
2.1e-01
5.6e-01
2.6e+00
1.0e+50
—
5.7e-01
6.9e-01
cases:2.85%
controls:2.31%
cases:1.09%
controls:0.63%
cases:0.65%
controls:0.05%
cases:1.44%
controls:0.00%
—
—
cases:1.30%
controls:0.74%
cases:5.07%
controls:2.62%
57
460
1946
19435
22
125
1989
19828
13
10
1998
19943
29
0
1982
19953
—
25
145
1892
19371
88
461
1648
17139
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
1.0e-01
2.6e-01
6.6e-01
2.3e+00
9.3e-01
2.4e-01
1.6e-02
cases:4.04%
controls:3.66%
cases:2.59%
controls:2.01%
cases:0.75%
controls:0.39%
cases:0.35%
controls:0.04%
cases:1.01%
controls:0.40%
cases:2.45%
controls:1.94%
cases:4.26%
controls:4.20%
81
729
1922
19166
52
402
1959
19551
15
77
1996
19876
7
7
2004
19946
20
80
1954
19835
47
379
1870
19137
74
739
1662
16861
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
4.3e-01
5.7e-01
1.1e+00
—
1.3e+00
5.3e-01
3.6e-01
cases:5.09%
controls:3.38%
cases:2.69%
controls:1.53%
cases:0.50%
controls:0.16%
—
—
cases:0.81%
controls:0.22%
cases:2.71%
controls:1.62%
cases:7.26%
controls:5.18%
102
672
1901
19223
54
306
1957
19647
10
32
2001
19921
—
16
43
1958
19872
52
316
1865
19200
126
911
1610
16689
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
7.8e-01
7.4e-01
—
—
2.4e+00
8.1e-01
4.2e-01
cases:1.40%
controls:0.65%
cases:0.65%
controls:0.31%
—
—
—
—
cases:0.46%
controls:0.04%
cases:0.78%
controls:0.35%
cases:1.96%
controls:1.29%
28
129
1975
19766
13
62
1998
19891
—
—
9
8
1965
19907
15
68
1902
19448
34
227
1702
17373
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
SPAT1220 [2001700321]
7.9e-01
1.3e+00
—
—
-1.0e+50
1.1e+00
1.1e+00
cases:1.25%
controls:0.57%
cases:0.65%
controls:0.19%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.57%
controls:0.19%
cases:1.32%
controls:0.43%
25
113
1978
19782
13
37
1998
19916
—
—
0
8
1974
19907
11
37
1906
19479
23
76
1713
17524
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
4.9e-01
5.1e-01
6.3e-01
—
1.1e+00
4.3e-01
6.6e-01
cases:26.26%
controls:17.92%
cases:8.25%
controls:5.15%
cases:0.94%
controls:0.51%
—
—
cases:1.37%
controls:0.48%
cases:7.25%
controls:4.82%
cases:24.88%
controls:14.58%
526
3566
1477
16329
166
1027
1845
18926
19
101
1992
19852
—
27
95
1947
19820
139
940
1778
18576
432
2566
1304
15034
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
3.5e-01
4.6e-01
7.3e-01
—
7.8e-01
4.4e-01
3.6e-01
cases:13.78%
controls:10.12%
cases:8.11%
controls:5.27%
cases:1.64%
controls:0.80%
—
—
cases:1.77%
controls:0.82%
cases:7.56%
controls:5.01%
cases:17.86%
controls:13.19%
276
2014
1727
17881
163
1052
1848
18901
33
159
1978
19794
—
35
164
1939
19751
145
978
1772
18538
310
2322
1426
15278
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
5.6e-01
2.5e-01
—
—
2.5e+00
5.4e-01
3.0e-01
cases:2.45%
controls:1.42%
cases:0.80%
controls:0.62%
—
—
—
—
cases:0.51%
controls:0.04%
cases:0.94%
controls:0.55%
cases:2.36%
controls:1.76%
49
282
1954
19613
16
124
1995
19829
—
—
10
8
1964
19907
18
107
1899
19409
41
309
1695
17291
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.1e-01
2.4e-01
4.4e-01
1.9e+00
5.4e-01
1.3e-01
1.4e-01
cases:22.62%
controls:20.70%
cases:18.85%
controls:15.48%
cases:4.38%
controls:2.85%
cases:0.85%
controls:0.13%
cases:4.56%
controls:2.72%
cases:18.15%
controls:16.26%
cases:33.64%
controls:30.66%
453
4118
1550
15777
379
3088
1632
16865
88
569
1923
19384
17
26
1994
19927
90
542
1884
19373
348
3173
1569
16343
584
5397
1152
12203
Foreign body entering into or through eye or natural orifice
W44 [45756297]
W44 [45756297]
—
—
—
1.0e+50
1.0e+50
1.0e+50
3.1e+00
—
—
—
—
—
—
cases:21.98%
controls:0.00%
cases:4.15%
controls:0.00%
cases:0.78%
controls:0.00%
cases:0.86%
controls:0.04%
—
—
—
442
0
1569
19953
82
0
1892
19915
15
0
1902
19516
15
7
1721
17593
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
7.4e-01
7.8e-01
1.3e+00
—
1.3e+00
9.0e-01
6.2e-01
cases:2.30%
controls:1.11%
cases:1.29%
controls:0.60%
cases:0.50%
controls:0.13%
—
—
cases:0.41%
controls:0.11%
cases:1.36%
controls:0.55%
cases:2.71%
controls:1.48%
46
220
1957
19675
26
119
1985
19834
10
26
2001
19927
—
8
21
1966
19894
26
108
1891
19408
47
260
1689
17340
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
J44.1 [45601132]
J44.1 [45601132]
1.6e+00
1.6e+00
—
—
—
1.6e+00
1.4e+00
cases:0.65%
controls:0.14%
cases:0.25%
controls:0.05%
—
—
—
—
—
—
cases:0.37%
controls:0.07%
cases:1.09%
controls:0.26%
13
27
1990
19868
5
10
2006
19943
—
—
—
7
14
1910
19502
19
46
1717
17554
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
4.4e-01
4.9e-01
8.3e-01
—
9.0e-01
3.4e-01
3.5e-01
cases:8.19%
controls:5.43%
cases:5.02%
controls:3.14%
cases:1.09%
controls:0.48%
—
—
cases:1.22%
controls:0.50%
cases:4.33%
controls:3.13%
cases:10.31%
controls:7.49%
164
1081
1839
18814
101
626
1910
19327
22
96
1989
19857
—
24
99
1950
19816
83
611
1834
18905
179
1318
1557
16282
Pain in throat
R07.0 [45592406]
R07.0 [45592406]
5.2e-01
1.0e+00
3.0e+00
1.0e+50
—
1.1e+00
7.0e-01
cases:0.75%
controls:0.45%
cases:0.40%
controls:0.14%
cases:0.50%
controls:0.03%
cases:0.70%
controls:0.00%
—
—
cases:0.47%
controls:0.15%
cases:1.32%
controls:0.66%
15
89
1988
19806
8
28
2003
19925
10
5
2001
19948
14
0
1997
19953
—
9
30
1908
19486
23
117
1713
17483
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
7.4e-01
1.2e+00
1.2e+00
—
—
1.0e+00
6.3e-01
cases:1.80%
controls:0.86%
cases:1.39%
controls:0.42%
cases:0.25%
controls:0.08%
—
—
—
—
cases:1.15%
controls:0.42%
cases:1.79%
controls:0.96%
36
172
1967
19723
28
84
1983
19869
5
15
2006
19938
—
—
22
82
1895
19434
31
169
1705
17431
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
8.1e-01
8.0e-01
3.2e-01
—
5.8e-01
6.4e-01
7.0e-01
cases:2.85%
controls:1.29%
cases:2.09%
controls:0.95%
cases:0.45%
controls:0.33%
—
—
cases:0.56%
controls:0.31%
cases:1.88%
controls:1.00%
cases:3.23%
controls:1.63%
57
256
1946
19639
42
189
1969
19764
9
65
2002
19888
—
11
62
1963
19853
36
195
1881
19321
56
287
1680
17313
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
2.7e-01
4.4e-01
3.9e-01
1.8e+00
5.5e-01
2.5e-01
4.4e-01
cases:10.38%
controls:8.15%
cases:7.61%
controls:5.04%
cases:1.94%
controls:1.32%
cases:0.55%
controls:0.09%
cases:2.03%
controls:1.17%
cases:6.36%
controls:5.04%
cases:15.84%
controls:10.85%
208
1622
1795
18273
153
1006
1858
18947
39
263
1972
19690
11
18
2000
19935
40
234
1934
19681
122
983
1795
18533
275
1910
1461
15690
salbutamol and ipratropium bromide
R03AL02 [43534844]
R03AL02 [43534844]
1.6e+00
1.5e+00
—
—
—
1.5e+00
1.3e+00
cases:0.45%
controls:0.09%
cases:0.25%
controls:0.06%
—
—
—
—
—
—
cases:0.31%
controls:0.07%
cases:0.63%
controls:0.17%
9
18
1994
19877
5
11
2006
19942
—
—
—
6
14
1911
19502
11
30
1725
17570
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
40988-8 [3044254]
1.2e+00
1.7e+00
—
—
-1.0e+50
—
7.6e-01
cases:0.80%
controls:0.24%
cases:0.55%
controls:0.10%
—
—
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.98%
controls:0.46%
16
48
1987
19847
11
20
2000
19933
—
—
0
5
1974
19910
—
17
81
1719
17519
hydrocortisone
S01CB03 [21603666]
S01CB03 [21603666]
1.6e+00
—
—
—
—
—
1.4e+00
cases:0.45%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.26%
9
19
1994
19876
—
—
—
—
—
17
45
1719
17555
hydrocortisone
S01BA02 [21603619]
S01BA02 [21603619]
1.6e+00
—
—
—
—
—
1.4e+00
cases:0.45%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.26%
9
19
1994
19876
—
—
—
—
—
17
45
1719
17555
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
5.3e-01
7.3e-01
8.5e-01
—
2.2e+00
-4.7e-02
1.4e-01
cases:1.85%
controls:1.09%
cases:1.29%
controls:0.63%
cases:0.40%
controls:0.17%
—
—
cases:0.61%
controls:0.07%
cases:0.63%
controls:0.66%
cases:2.30%
controls:2.00%
37
217
1966
19678
26
125
1985
19828
8
34
2003
19919
—
12
14
1962
19901
12
128
1905
19388
40
352
1696
17248
Tonsillectomy
EMB10 [2001302265]
EMB10 [2001302265]
4.2e-01
—
—
—
—
1.6e+00
1.2e+00
cases:0.55%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.09%
cases:1.09%
controls:0.32%
11
72
1992
19823
—
—
—
—
9
18
1908
19498
19
56
1717
17544
mometasone; nasal
R01AD09 [21605051]
R01AD09 [21605051]
4.4e-01
5.3e-01
7.7e-01
—
9.1e-01
4.3e-01
5.7e-01
cases:11.43%
controls:7.67%
cases:5.02%
controls:3.03%
cases:0.75%
controls:0.35%
—
—
cases:1.06%
controls:0.43%
cases:4.80%
controls:3.19%
cases:14.98%
controls:9.04%
229
1526
1774
18369
101
605
1910
19348
15
69
1996
19884
—
21
86
1953
19829
92
622
1825
18894
260
1591
1476
16009
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
5.4e-01
4.9e-01
3.6e-01
—
1.2e+00
3.9e-01
6.1e-01
cases:4.59%
controls:2.73%
cases:2.88%
controls:1.79%
cases:0.50%
controls:0.35%
—
—
cases:0.91%
controls:0.28%
cases:2.82%
controls:1.92%
cases:6.80%
controls:3.82%
92
543
1911
19352
58
358
1953
19595
10
69
2001
19884
—
18
56
1956
19859
54
375
1863
19141
118
672
1618
16928
epinephrine
S01EA01 [21603673]
S01EA01 [21603673]
6.8e-01
7.2e-01
—
—
—
1.2e+00
9.4e-01
cases:1.70%
controls:0.86%
cases:0.70%
controls:0.34%
—
—
—
—
—
—
cases:1.25%
controls:0.39%
cases:2.19%
controls:0.86%
34
172
1969
19723
14
68
1997
19885
—
—
—
24
76
1893
19440
38
152
1698
17448
epinephrine; parenteral
C01CA24 [21600303]
C01CA24 [21600303]
6.8e-01
7.2e-01
—
—
—
1.2e+00
9.4e-01
cases:1.70%
controls:0.86%
cases:0.70%
controls:0.34%
—
—
—
—
—
—
cases:1.25%
controls:0.39%
cases:2.19%
controls:0.86%
34
172
1969
19723
14
68
1997
19885
—
—
—
24
76
1893
19440
38
152
1698
17448
Wrist and hand extensive MRI examination with high intensity magnet
ND1CG [2001307593]
ND1CG [2001307593]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.03%
—
—
—
—
—
—
8
5
1728
17595
Knee X-ray examination without contrast
NG1AA [2001308049]
NG1AA [2001308049]
8.4e-01
7.6e-01
—
—
—
1.2e+00
7.3e-01
cases:1.85%
controls:0.80%
cases:0.55%
controls:0.26%
—
—
—
—
—
—
cases:0.78%
controls:0.24%
cases:2.02%
controls:0.98%
37
160
1966
19735
11
51
2000
19902
—
—
—
15
46
1902
19470
35
172
1701
17428
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
4.8e-01
6.1e-01
6.6e-01
—
4.9e-01
5.0e-01
5.2e-01
cases:17.37%
controls:11.50%
cases:10.44%
controls:5.98%
cases:1.74%
controls:0.91%
—
—
cases:1.72%
controls:1.06%
cases:9.60%
controls:6.06%
cases:21.60%
controls:14.07%
348
2288
1655
17607
210
1193
1801
18760
35
181
1976
19772
—
34
212
1940
19703
184
1183
1733
18333
375
2477
1361
15123
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.6e-01
4.3e-01
7.9e-01
—
1.2e+00
2.5e-01
3.7e-01
cases:7.34%
controls:5.76%
cases:5.22%
controls:3.44%
cases:1.34%
controls:0.61%
—
—
cases:1.57%
controls:0.50%
cases:4.17%
controls:3.27%
cases:10.71%
controls:7.62%
147
1146
1856
18749
105
687
1906
19266
27
122
1984
19831
—
31
99
1943
19816
80
638
1837
18878
186
1341
1550
16259
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
5.1e-01
7.6e-01
9.1e-01
—
2.0e+00
3.4e-02
1.5e-01
cases:1.75%
controls:1.06%
cases:1.29%
controls:0.61%
cases:0.40%
controls:0.16%
—
—
cases:0.56%
controls:0.08%
cases:0.68%
controls:0.66%
cases:2.25%
controls:1.94%
35
210
1968
19685
26
122
1985
19831
8
32
2003
19921
—
11
15
1963
19900
13
128
1904
19388
39
341
1697
17259
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
5.2e-01
6.2e-01
1.3e+00
—
—
8.6e-01
7.6e-01
cases:4.84%
controls:2.95%
cases:1.84%
controls:1.00%
cases:0.40%
controls:0.11%
—
—
—
—
cases:2.09%
controls:0.89%
cases:7.26%
controls:3.54%
97
587
1906
19308
37
199
1974
19754
8
21
2003
19932
—
—
40
174
1877
19342
126
623
1610
16977
Chronic rhinitis
J31.0 [45572165]
J31.0 [45572165]
8.3e-01
1.2e+00
—
—
-1.0e+50
9.6e-01
7.6e-01
cases:1.40%
controls:0.61%
cases:0.80%
controls:0.25%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.63%
controls:0.24%
cases:1.50%
controls:0.70%
28
122
1975
19773
16
50
1995
19903
—
—
0
7
1974
19908
12
47
1905
19469
26
124
1710
17476
Flexible laryngoscopy
UDQ12 [2001301827]
UDQ12 [2001301827]
7.5e-01
1.4e+00
—
1.0e+50
—
1.7e+00
1.0e+00
cases:0.75%
controls:0.36%
cases:0.35%
controls:0.09%
—
—
cases:3.23%
controls:0.00%
—
—
cases:0.42%
controls:0.08%
cases:1.09%
controls:0.39%
15
71
1988
19824
7
18
2004
19935
—
65
0
1946
19953
—
8
15
1909
19501
19
69
1717
17531
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
4.5e-01
8.3e-01
2.3e+00
—
2.7e+00
2.8e-01
3.9e-01
cases:1.00%
controls:0.64%
cases:0.60%
controls:0.26%
cases:0.25%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:0.31%
controls:0.24%
cases:1.21%
controls:0.82%
20
127
1983
19768
12
52
1999
19901
5
5
2006
19948
—
9
6
1965
19909
6
46
1911
19470
21
145
1715
17455
phenoxymethylpenicillin; oral
J01CE02 [21602842]
J01CE02 [21602842]
2.6e-01
4.9e-01
7.9e-01
—
1.4e+00
5.7e-01
2.3e-01
cases:16.08%
controls:12.87%
cases:5.07%
controls:3.16%
cases:0.70%
controls:0.32%
—
—
cases:1.27%
controls:0.32%
cases:5.48%
controls:3.18%
cases:15.38%
controls:12.59%
322
2560
1681
17335
102
630
1909
19323
14
63
1997
19890
—
25
63
1949
19852
105
620
1812
18896
267
2215
1469
15385
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
J01CE10 [21602850]
2.6e-01
4.9e-01
7.9e-01
—
1.4e+00
5.7e-01
2.3e-01
cases:16.08%
controls:12.87%
cases:5.07%
controls:3.16%
cases:0.70%
controls:0.32%
—
—
cases:1.27%
controls:0.32%
cases:5.48%
controls:3.18%
cases:15.38%
controls:12.59%
322
2560
1681
17335
102
630
1909
19323
14
63
1997
19890
—
25
63
1949
19852
105
620
1812
18896
267
2215
1469
15385
Tracheostomy
GBB00 [2001303560]
GBB00 [2001303560]
2.7e+00
—
—
—
—
—
—
cases:0.45%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
9
6
1994
19889
—
—
—
—
—
—
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
3.8e-01
3.3e-01
1.2e+00
—
2.0e+00
5.3e-01
7.0e-01
cases:3.69%
controls:2.56%
cases:1.04%
controls:0.75%
cases:0.30%
controls:0.09%
—
—
cases:0.41%
controls:0.06%
cases:1.25%
controls:0.74%
cases:4.90%
controls:2.49%
74
510
1929
19385
21
150
1990
19803
6
18
2005
19935
—
8
11
1966
19904
24
144
1893
19372
85
439
1651
17161
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
30934-4 [3011960]
6.0e-01
5.7e-01
—
—
2.1e+00
7.4e-01
6.1e-01
cases:2.00%
controls:1.11%
cases:0.85%
controls:0.48%
—
—
—
—
cases:0.41%
controls:0.05%
cases:0.83%
controls:0.40%
cases:1.79%
controls:0.98%
40
220
1963
19675
17
96
1994
19857
—
—
8
10
1966
19905
16
78
1901
19438
31
173
1705
17427
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
76080-1 [46235759]
1.1e+00
1.6e+00
—
—
—
—
8.2e-01
cases:0.90%
controls:0.31%
cases:0.60%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.51%
18
61
1985
19834
12
24
1999
19929
—
—
—
—
20
90
1716
17510
Oesophageal obstruction
K22.2 [45552917]
K22.2 [45552917]
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.37%
controls:0.03%
—
—
—
—
—
—
—
7
5
1910
19511
—
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
6.1e-01
6.7e-01
9.1e-01
—
9.3e-01
5.8e-01
7.9e-01
cases:7.89%
controls:4.45%
cases:2.73%
controls:1.42%
cases:0.35%
controls:0.14%
—
—
cases:0.41%
controls:0.16%
cases:2.45%
controls:1.39%
cases:10.66%
controls:5.14%
158
885
1845
19010
55
284
1956
19669
7
28
2004
19925
—
8
32
1966
19883
47
272
1870
19244
185
904
1551
16696
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
2.3e-01
2.8e-01
5.7e-01
2.6e+00
3.8e-01
1.3e-01
6.6e-02
cases:13.03%
controls:10.64%
cases:7.26%
controls:5.61%
cases:1.24%
controls:0.71%
cases:0.35%
controls:0.03%
cases:0.96%
controls:0.66%
cases:6.21%
controls:5.50%
cases:15.50%
controls:14.65%
261
2116
1742
17779
146
1119
1865
18834
25
141
1986
19812
7
5
2004
19948
19
132
1955
19783
119
1073
1798
18443
269
2579
1467
15021
Dry eye syndrome
H04.10 [2000502254]
H04.10 [2000502254]
7.9e-01
1.0e+00
—
—
—
4.8e-01
8.0e-01
cases:1.60%
controls:0.73%
cases:0.80%
controls:0.29%
—
—
—
—
—
—
cases:0.52%
controls:0.32%
cases:2.59%
controls:1.18%
32
145
1971
19750
16
58
1995
19895
—
—
—
10
63
1907
19453
45
207
1691
17393
Endoscopic excision of lesion of larynx
DQB10 [2001301845]
DQB10 [2001301845]
2.6e+00
—
—
—
—
—
—
cases:0.40%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
8
6
1995
19889
—
—
—
—
—
—
Gastroenterology
10 [38004455]
10 [38004455]
5.3e-01
6.0e-01
6.3e-01
—
-2.1e-01
7.3e-01
6.9e-01
cases:5.74%
controls:3.47%
cases:2.83%
controls:1.57%
cases:0.55%
controls:0.29%
—
—
cases:0.25%
controls:0.31%
cases:3.08%
controls:1.51%
cases:8.35%
controls:4.36%
115
691
1888
19204
57
313
1954
19640
11
58
2000
19895
—
5
62
1969
19853
59
294
1858
19222
145
768
1591
16832
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
1.3e-01
9.6e-01
—
—
—
8.8e-01
7.1e-01
cases:1.85%
controls:1.62%
cases:1.04%
controls:0.40%
—
—
—
—
—
—
cases:0.99%
controls:0.42%
cases:3.28%
controls:1.64%
37
322
1966
19573
21
80
1990
19873
—
—
—
19
81
1898
19435
57
288
1679
17312
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
8.0e-01
5.6e-01
8.8e-02
-1.0e+50
8.5e-02
5.2e-01
6.7e-01
cases:4.39%
controls:2.03%
cases:2.69%
controls:1.56%
cases:0.55%
controls:0.50%
cases:0.00%
controls:0.03%
cases:0.56%
controls:0.51%
cases:2.82%
controls:1.69%
cases:5.41%
controls:2.84%
88
403
1915
19492
54
311
1957
19642
11
100
2000
19853
0
5
2011
19948
11
102
1963
19813
54
329
1863
19187
94
500
1642
17100
Deviated nasal septum
J34.2 [45562448]
J34.2 [45562448]
4.6e-01
1.2e+00
—
—
—
1.5e+00
1.1e+00
cases:0.55%
controls:0.35%
cases:0.30%
controls:0.09%
—
—
—
—
—
—
cases:0.47%
controls:0.11%
cases:0.92%
controls:0.32%
11
69
1992
19826
6
18
2005
19935
—
—
—
9
21
1908
19495
16
56
1720
17544
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
1.1e+00
7.4e-01
1.7e+00
—
—
1.4e+00
6.3e-01
cases:1.20%
controls:0.41%
cases:0.40%
controls:0.19%
cases:0.25%
controls:0.05%
—
—
—
—
cases:0.89%
controls:0.22%
cases:1.32%
controls:0.71%
24
81
1979
19814
8
38
2003
19915
5
9
2006
19944
—
—
17
42
1900
19474
23
125
1713
17475
Pneumonitis due to food and vomit
J69.0 [45591562]
J69.0 [45591562]
1.3e+00
—
—
1.0e+50
—
2.5e+00
1.7e+00
cases:0.30%
controls:0.09%
—
—
—
—
cases:0.70%
controls:0.00%
—
—
cases:0.31%
controls:0.03%
cases:0.40%
controls:0.07%
6
17
1997
19878
—
—
14
0
1997
19953
—
6
5
1911
19511
7
13
1729
17587
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
-2.2e-01
—
-1.0e+50
—
2.5e+00
4.0e-01
6.3e-01
cases:0.45%
controls:0.56%
—
—
cases:0.00%
controls:0.09%
—
—
cases:0.30%
controls:0.03%
cases:0.37%
controls:0.25%
cases:0.98%
controls:0.52%
9
111
1994
19784
—
0
17
2011
19936
—
6
5
1968
19910
7
48
1910
19468
17
92
1719
17508
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
7.2e-01
8.5e-01
1.7e+00
—
2.5e+00
—
-2.0e-01
cases:0.65%
controls:0.32%
cases:0.40%
controls:0.17%
cases:0.25%
controls:0.05%
—
—
cases:0.30%
controls:0.03%
—
—
cases:0.81%
controls:0.98%
13
63
1990
19832
8
34
2003
19919
5
9
2006
19944
—
6
5
1968
19910
—
14
173
1722
17427
Temporomandibular joint-pain-dysfunction syndrome
K07.65 [2000502796]
K07.65 [2000502796]
2.5e+00
—
—
—
—
—
—
cases:0.30%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
1997
19890
—
—
—
—
—
—
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
ZXE15 [2001311406]
1.7e-01
—
—
—
—
—
2.5e+00
cases:0.25%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.03%
5
42
1998
19853
—
—
—
—
—
7
6
1729
17594
budesonide; inhalant
R03BA02 [21603285]
R03BA02 [21603285]
6.3e-01
6.0e-01
5.7e-01
—
4.0e-01
5.8e-01
6.6e-01
cases:8.84%
controls:4.93%
cases:5.22%
controls:2.94%
cases:1.19%
controls:0.68%
—
—
cases:1.06%
controls:0.72%
cases:5.22%
controls:2.98%
cases:9.62%
controls:5.21%
177
981
1826
18914
105
586
1906
19367
24
135
1987
19818
—
21
143
1953
19772
100
581
1817
18935
167
917
1569
16683
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
4.7e-01
1.1e+00
—
—
2.5e+00
—
-4.7e-01
cases:0.65%
controls:0.41%
cases:0.60%
controls:0.21%
—
—
—
—
cases:0.35%
controls:0.03%
—
—
cases:0.63%
controls:1.01%
13
81
1990
19814
12
41
1999
19912
—
—
7
6
1967
19909
—
11
178
1725
17422
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
4.0e-01
6.6e-01
1.1e+00
—
1.8e+00
5.3e-01
2.9e-01
cases:3.15%
controls:2.12%
cases:1.79%
controls:0.93%
cases:0.35%
controls:0.12%
—
—
cases:0.81%
controls:0.14%
cases:1.72%
controls:1.02%
cases:4.32%
controls:3.28%
63
422
1940
19473
36
186
1975
19767
7
24
2004
19929
—
16
27
1958
19888
33
199
1884
19317
75
577
1661
17023
Ptosis of eyelid
H02.4 [45605583]
H02.4 [45605583]
1.3e+00
2.5e+00
—
—
—
—
2.9e-01
cases:0.50%
controls:0.14%
cases:0.35%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.22%
10
28
1993
19867
7
6
2004
19947
—
—
—
—
5
38
1731
17562
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
7.2e-01
8.6e-01
—
1.0e+50
8.8e-01
6.2e-01
8.5e-01
cases:2.30%
controls:1.13%
cases:1.19%
controls:0.51%
—
—
cases:0.25%
controls:0.00%
cases:0.25%
controls:0.11%
cases:0.94%
controls:0.51%
cases:2.82%
controls:1.22%
46
225
1957
19670
24
101
1987
19852
—
5
0
2006
19953
5
21
1969
19894
18
99
1899
19417
49
215
1687
17385
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
3.4e-01
9.0e-02
2.6e-01
—
1.4e+00
6.4e-01
4.1e-01
cases:3.84%
controls:2.78%
cases:1.34%
controls:1.23%
cases:0.30%
controls:0.23%
—
—
cases:0.61%
controls:0.16%
cases:2.35%
controls:1.25%
cases:5.93%
controls:4.00%
77
553
1926
19342
27
245
1984
19708
6
46
2005
19907
—
12
31
1962
19884
45
244
1872
19272
103
704
1633
16896
roxithromycin; oral
J01FA06 [21602974]
J01FA06 [21602974]
4.2e-01
8.9e-01
—
—
1.4e+00
6.8e-01
4.2e-01
cases:7.79%
controls:5.25%
cases:3.03%
controls:1.26%
—
—
—
—
cases:0.35%
controls:0.09%
cases:2.24%
controls:1.15%
cases:5.65%
controls:3.79%
156
1044
1847
18851
61
252
1950
19701
—
—
7
18
1967
19897
43
224
1874
19292
98
667
1638
16933
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
9.8e-01
1.4e+00
—
1.0e+50
—
—
2.2e-01
cases:0.85%
controls:0.32%
cases:0.50%
controls:0.12%
—
—
cases:0.35%
controls:0.00%
—
—
—
—
cases:0.81%
controls:0.65%
17
64
1986
19831
10
24
2001
19929
—
7
0
2004
19953
—
—
14
114
1722
17486
clonazepam; oral, parenteral
N03AE01 [21604415]
N03AE01 [21604415]
8.5e-01
6.3e-01
1.1e+00
—
6.7e-01
8.0e-01
7.5e-01
cases:1.65%
controls:0.71%
cases:0.94%
controls:0.51%
cases:0.50%
controls:0.16%
—
—
cases:0.30%
controls:0.16%
cases:1.25%
controls:0.57%
cases:1.67%
controls:0.80%
33
142
1970
19753
19
101
1992
19852
10
32
2001
19921
—
6
31
1968
19884
24
111
1893
19405
29
140
1707
17460
prednisone
A07EA03 [21600655]
A07EA03 [21600655]
7.3e-01
8.6e-01
—
—
-1.0e+50
3.0e-01
7.9e-01
cases:2.65%
controls:1.29%
cases:1.04%
controls:0.45%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.57%
controls:0.43%
cases:2.48%
controls:1.14%
53
257
1950
19638
21
89
1990
19864
—
—
0
10
1974
19905
11
83
1906
19433
43
201
1693
17399
prednisone; oral
H02AB07 [21602735]
H02AB07 [21602735]
7.3e-01
8.6e-01
—
—
-1.0e+50
3.0e-01
7.9e-01
cases:2.65%
controls:1.29%
cases:1.04%
controls:0.45%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.57%
controls:0.43%
cases:2.48%
controls:1.14%
53
257
1950
19638
21
89
1990
19864
—
—
0
10
1974
19905
11
83
1906
19433
43
201
1693
17399
Specific (isolated) phobias
F40.2 [45586240]
F40.2 [45586240]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.03%
—
—
—
—
—
—
6
6
1730
17594
ziprasidone; oral, parenteral
N05AE04 [21604529]
N05AE04 [21604529]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.03%
—
—
—
—
—
—
5
5
1731
17595
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
7.4e-01
7.2e-01
1.7e+00
—
2.3e+00
—
-1.9e-01
cases:0.65%
controls:0.31%
cases:0.35%
controls:0.17%
cases:0.25%
controls:0.05%
—
—
cases:0.30%
controls:0.03%
—
—
cases:0.81%
controls:0.98%
13
62
1990
19833
7
34
2004
19919
5
9
2006
19944
—
6
6
1968
19909
—
14
172
1722
17428
Stomatognathic treatment, demanding
SHA03 [2001310407]
SHA03 [2001310407]
1.1e+00
1.6e+00
—
—
—
9.8e-01
1.2e+00
cases:0.70%
controls:0.24%
cases:0.35%
controls:0.07%
—
—
—
—
—
—
cases:0.31%
controls:0.12%
cases:0.98%
controls:0.28%
14
48
1989
19847
7
14
2004
19939
—
—
—
6
23
1911
19493
17
50
1719
17550
beclometasone; inhalant
R03BA01 [21603284]
R03BA01 [21603284]
4.9e-01
5.9e-01
3.5e-01
—
1.9e-01
6.7e-01
5.5e-01
cases:3.49%
controls:2.17%
cases:1.94%
controls:1.08%
cases:0.30%
controls:0.21%
—
—
cases:0.30%
controls:0.25%
cases:2.14%
controls:1.10%
cases:3.23%
controls:1.89%
70
431
1933
19464
39
216
1972
19737
6
42
2005
19911
—
6
50
1968
19865
41
215
1876
19301
56
332
1680
17268
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
4.4e-01
6.4e-01
5.9e-01
—
-3.3e-01
6.4e-01
5.7e-01
cases:16.67%
controls:11.40%
cases:5.47%
controls:2.96%
cases:0.60%
controls:0.33%
—
—
cases:0.25%
controls:0.35%
cases:5.32%
controls:2.88%
cases:14.46%
controls:8.73%
334
2268
1669
17627
110
591
1901
19362
12
66
1999
19887
—
5
70
1969
19845
102
563
1815
18953
251
1537
1485
16063
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
5.2e-01
6.0e-01
3.8e-01
—
4.3e-01
6.3e-01
5.3e-01
cases:3.89%
controls:2.35%
cases:2.78%
controls:1.54%
cases:0.75%
controls:0.51%
—
—
cases:0.81%
controls:0.53%
cases:3.03%
controls:1.63%
cases:5.13%
controls:3.09%
78
468
1925
19427
56
308
1955
19645
15
102
1996
19851
—
16
105
1958
19810
58
318
1859
19198
89
544
1647
17056
clozapine; oral, parenteral
N05AH02 [21604542]
N05AH02 [21604542]
1.1e+00
1.2e+00
9.4e-01
—
1.0e+00
8.9e-01
9.1e-01
cases:0.75%
controls:0.25%
cases:0.70%
controls:0.22%
cases:0.50%
controls:0.20%
—
—
cases:0.51%
controls:0.19%
cases:0.57%
controls:0.24%
cases:0.58%
controls:0.23%
15
49
1988
19846
14
44
1997
19909
10
39
2001
19914
—
10
37
1964
19878
11
46
1906
19470
10
41
1726
17559
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
8.1e-01
7.1e-01
1.0e+00
—
1.1e+00
5.7e-01
7.2e-01
cases:4.94%
controls:2.26%
cases:2.39%
controls:1.19%
cases:0.60%
controls:0.21%
—
—
cases:0.51%
controls:0.18%
cases:1.83%
controls:1.04%
cases:5.65%
controls:2.84%
99
450
1904
19445
48
238
1963
19715
12
42
1999
19911
—
10
35
1964
19880
35
203
1882
19313
98
500
1638
17100
escitalopram; oral
N06AB10 [21604718]
N06AB10 [21604718]
5.5e-01
6.4e-01
6.2e-01
—
7.6e-01
5.2e-01
5.2e-01
cases:4.44%
controls:2.60%
cases:2.64%
controls:1.41%
cases:0.80%
controls:0.43%
—
—
cases:0.96%
controls:0.45%
cases:2.76%
controls:1.67%
cases:5.47%
controls:3.32%
89
518
1914
19377
53
282
1958
19671
16
86
1995
19867
—
19
90
1955
19825
53
325
1864
19191
95
585
1641
17015
Percutaneous gastrostomy
JDB10 [2001304713]
JDB10 [2001304713]
2.2e+00
—
—
—
—
—
-1.0e+50
cases:0.60%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
12
13
1991
19882
—
—
—
—
—
0
7
1736
17593
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
5.9e-01
8.5e-01
1.2e+00
—
—
5.7e-01
7.8e-01
cases:4.14%
controls:2.34%
cases:1.64%
controls:0.71%
cases:0.25%
controls:0.08%
—
—
—
—
cases:1.51%
controls:0.86%
cases:5.70%
controls:2.70%
83
466
1920
19429
33
141
1978
19812
5
15
2006
19938
—
—
29
168
1888
19348
99
476
1637
17124
Hypertrophy of nasal turbinates
J34.3 [45543264]
J34.3 [45543264]
1.2e+00
—
—
—
—
—
2.2e+00
cases:0.35%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.06%
7
20
1996
19875
—
—
—
—
—
9
10
1727
17590
General medical examination
Z00.0 [45585791]
Z00.0 [45585791]
3.4e-01
5.0e-01
—
1.0e+50
2.2e+00
3.4e-01
4.2e-01
cases:2.55%
controls:1.83%
cases:0.90%
controls:0.55%
—
—
cases:0.35%
controls:0.00%
cases:0.46%
controls:0.05%
cases:0.78%
controls:0.56%
cases:3.23%
controls:2.14%
51
365
1952
19530
18
109
1993
19844
—
7
0
2004
19953
9
10
1965
19905
15
109
1902
19407
56
376
1680
17224
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
5.0e-01
6.9e-01
5.3e-01
—
6.5e-01
4.4e-01
5.7e-01
cases:12.48%
controls:7.97%
cases:6.86%
controls:3.57%
cases:1.09%
controls:0.65%
—
—
cases:1.27%
controls:0.67%
cases:5.63%
controls:3.69%
cases:15.26%
controls:9.24%
250
1585
1753
18310
138
712
1873
19241
22
129
1989
19824
—
25
133
1949
19782
108
720
1809
18796
265
1626
1471
15974
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
5.0e-01
6.9e-01
5.3e-01
—
6.6e-01
4.5e-01
5.6e-01
cases:12.43%
controls:7.95%
cases:6.86%
controls:3.56%
cases:1.09%
controls:0.65%
—
—
cases:1.27%
controls:0.66%
cases:5.63%
controls:3.67%
cases:15.09%
controls:9.21%
249
1581
1754
18314
138
710
1873
19243
22
129
1989
19824
—
25
131
1949
19784
108
717
1809
18799
262
1621
1474
15979
Protein [Mass/volume] in Pleural fluid
2882-9 [3003434]
2882-9 [3003434]
2.2e+00
—
—
—
—
—
—
cases:0.45%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
9
10
1994
19885
—
—
—
—
—
—
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60022-1 [40763082]
60022-1 [40763082]
2.2e+00
-1.0e+50
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
7
8
1996
19887
0
5
2011
19948
—
—
—
—
—
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
5.1e-01
6.6e-01
—
—
2.2e+00
—
-4.3e-01
cases:0.60%
controls:0.36%
cases:0.40%
controls:0.21%
—
—
—
—
cases:0.30%
controls:0.04%
—
—
cases:0.69%
controls:1.06%
12
72
1991
19823
8
41
2003
19912
—
—
6
7
1968
19908
—
12
187
1724
17413
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
6.8e-01
5.3e-01
1.2e+00
—
5.5e-01
8.3e-01
6.5e-01
cases:3.05%
controls:1.57%
cases:1.09%
controls:0.65%
cases:0.45%
controls:0.14%
—
—
cases:0.25%
controls:0.15%
cases:1.25%
controls:0.55%
cases:3.69%
controls:1.97%
61
312
1942
19583
22
129
1989
19824
9
27
2002
19926
—
5
29
1969
19886
24
107
1893
19409
64
346
1672
17254
Obesity
E66 [45547648]
E66 [45547648]
1.1e+00
9.5e-01
-1.0e+50
—
—
4.7e-01
1.0e+00
cases:0.70%
controls:0.23%
cases:0.35%
controls:0.14%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.26%
controls:0.16%
cases:1.27%
controls:0.45%
14
46
1989
19849
7
27
2004
19926
0
5
2011
19948
—
—
5
32
1912
19484
22
79
1714
17521
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
3.5e-01
7.1e-01
6.2e-01
—
3.0e-01
5.0e-01
5.8e-01
cases:16.48%
controls:12.20%
cases:7.26%
controls:3.69%
cases:0.99%
controls:0.54%
—
—
cases:0.71%
controls:0.53%
cases:6.16%
controls:3.81%
cases:19.47%
controls:11.93%
330
2428
1673
17467
146
737
1865
19216
20
107
1991
19846
—
14
105
1960
19810
118
744
1799
18772
338
2099
1398
15501
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
35704-6 [3036428]
35704-6 [3036428]
2.1e+00
-1.0e+50
—
—
—
—
—
cases:0.30%
controls:0.04%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
6
7
1997
19888
0
5
2011
19948
—
—
—
—
—
Haemorrhage, not elsewhere classified
R58 [45573033]
R58 [45573033]
2.1e+00
—
—
—
—
—
—
cases:0.30%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
1997
19888
—
—
—
—
—
—
Paralysis of vocal cords and larynx
J38.0 [45543265]
J38.0 [45543265]
2.1e+00
—
—
—
—
—
—
cases:0.55%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
11
13
1992
19882
—
—
—
—
—
—
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
8.5e-01
1.3e+00
—
—
—
4.2e-01
6.2e-01
cases:1.50%
controls:0.64%
cases:0.70%
controls:0.20%
—
—
—
—
—
—
cases:0.37%
controls:0.24%
cases:1.15%
controls:0.63%
30
128
1973
19767
14
39
1997
19914
—
—
—
7
47
1910
19469
20
110
1716
17490
Erythematous condition, unspecified
L53.9 [45577042]
L53.9 [45577042]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.06%
—
—
—
—
—
—
9
11
1727
17589
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
2.0e-01
4.1e-01
—
—
1.6e+00
6.4e-01
4.9e-01
cases:2.75%
controls:2.25%
cases:1.09%
controls:0.73%
—
—
—
—
cases:0.46%
controls:0.09%
cases:1.15%
controls:0.61%
cases:4.55%
controls:2.84%
55
448
1948
19447
22
146
1989
19807
—
—
9
18
1965
19897
22
119
1895
19397
79
500
1657
17100
lithium; oral
N05AN01 [21604556]
N05AN01 [21604556]
1.0e+00
1.1e+00
—
—
—
1.1e+00
8.7e-01
cases:0.80%
controls:0.29%
cases:0.65%
controls:0.22%
—
—
—
—
—
—
cases:0.63%
controls:0.22%
cases:0.69%
controls:0.29%
16
57
1987
19838
13
44
1998
19909
—
—
—
12
42
1905
19474
12
51
1724
17549
Other somatoform disorders
F45.8 [45600750]
F45.8 [45600750]
9.9e-02
6.9e-01
—
—
—
1.3e+00
7.6e-01
cases:0.60%
controls:0.54%
cases:0.35%
controls:0.18%
—
—
—
—
—
—
cases:0.83%
controls:0.22%
cases:1.44%
controls:0.68%
12
108
1991
19787
7
35
2004
19918
—
—
—
16
43
1901
19473
25
119
1711
17481
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
1.1e+00
6.3e-01
—
—
—
5.0e-01
9.5e-01
cases:1.25%
controls:0.40%
cases:0.35%
controls:0.19%
—
—
—
—
—
—
cases:0.26%
controls:0.16%
cases:1.32%
controls:0.52%
25
80
1978
19815
7
37
2004
19916
—
—
—
5
31
1912
19485
23
91
1713
17509
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
5.8e-01
4.3e-01
9.3e-01
—
5.9e-01
4.3e-01
5.6e-01
cases:7.19%
controls:4.15%
cases:2.93%
controls:1.93%
cases:0.94%
controls:0.38%
—
—
cases:0.66%
controls:0.37%
cases:3.08%
controls:2.02%
cases:7.20%
controls:4.23%
144
825
1859
19070
59
385
1952
19568
19
75
1992
19878
—
13
73
1961
19842
59
394
1858
19122
125
744
1611
16856
vilanterol and fluticasone furoate
R03AK10 [43534841]
R03AK10 [43534841]
7.9e-01
1.2e+00
—
—
1.3e+00
9.6e-01
8.4e-01
cases:0.65%
controls:0.30%
cases:0.75%
controls:0.22%
—
—
—
—
cases:0.30%
controls:0.09%
cases:0.68%
controls:0.26%
cases:1.27%
controls:0.55%
13
59
1990
19836
15
44
1996
19909
—
—
6
17
1968
19898
13
51
1904
19465
22
97
1714
17503
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
2.7e-01
—
-1.0e+50
1.0e+50
2.1e+00
1.0e+00
6.4e-01
cases:0.95%
controls:0.73%
—
—
cases:0.00%
controls:0.04%
cases:0.65%
controls:0.00%
cases:0.35%
controls:0.05%
cases:0.57%
controls:0.20%
cases:1.32%
controls:0.70%
19
145
1984
19750
—
0
7
2011
19946
13
0
1998
19953
7
9
1967
19906
11
40
1906
19476
23
124
1713
17476
fluticasone; nasal
R01AD08 [21605050]
R01AD08 [21605050]
5.0e-01
5.2e-01
1.1e-01
—
4.1e-01
4.8e-01
5.5e-01
cases:11.93%
controls:7.59%
cases:5.37%
controls:3.25%
cases:0.50%
controls:0.45%
—
—
cases:0.76%
controls:0.51%
cases:5.06%
controls:3.20%
cases:13.19%
controls:8.06%
239
1510
1764
18385
108
649
1903
19304
10
89
2001
19864
—
15
101
1959
19814
97
624
1820
18892
229
1419
1507
16181
fluticasone furoate; nasal
R01AD12 [21605053]
R01AD12 [21605053]
5.0e-01
5.2e-01
1.1e-01
—
4.1e-01
4.8e-01
5.5e-01
cases:11.93%
controls:7.59%
cases:5.37%
controls:3.25%
cases:0.50%
controls:0.45%
—
—
cases:0.76%
controls:0.51%
cases:5.06%
controls:3.20%
cases:13.19%
controls:8.06%
239
1510
1764
18385
108
649
1903
19304
10
89
2001
19864
—
15
101
1959
19814
97
624
1820
18892
229
1419
1507
16181
Anxiety disorder, unspecified
F41.9 [45542849]
F41.9 [45542849]
2.6e-01
1.4e+00
—
—
—
4.0e-01
6.4e-01
cases:1.15%
controls:0.88%
cases:1.19%
controls:0.30%
—
—
—
—
—
—
cases:0.57%
controls:0.38%
cases:2.02%
controls:1.07%
23
176
1980
19719
24
59
1987
19894
—
—
—
11
75
1906
19441
35
188
1701
17412
Differential panel - Pleural fluid
29583-2 [3012441]
29583-2 [3012441]
2.0e+00
-1.0e+50
—
—
—
—
—
cases:0.35%
controls:0.05%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
7
9
1996
19886
0
6
2011
19947
—
—
—
—
—
Pleura Pathology biopsy report
66123-1 [40768806]
66123-1 [40768806]
2.0e+00
-1.0e+50
—
—
—
—
—
cases:0.35%
controls:0.05%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
7
9
1996
19886
0
5
2011
19948
—
—
—
—
—
Leukocytes [#/volume] in Pleural fluid
26467-1 [3023199]
26467-1 [3023199]
2.0e+00
—
—
—
—
—
—
cases:0.35%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
7
9
1996
19886
—
—
—
—
—
—
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
3.9e-01
4.3e-01
—
—
—
1.2e+00
8.4e-01
cases:1.25%
controls:0.84%
cases:0.45%
controls:0.29%
—
—
—
—
—
—
cases:0.78%
controls:0.24%
cases:1.90%
controls:0.83%
25
168
1978
19727
9
58
2002
19895
—
—
—
15
46
1902
19470
33
146
1703
17454
ebastine; oral
R06AX22 [21603521]
R06AX22 [21603521]
6.0e-01
5.5e-01
6.5e-01
—
6.2e-01
6.7e-01
7.6e-01
cases:4.09%
controls:2.29%
cases:2.04%
controls:1.18%
cases:0.30%
controls:0.16%
—
—
cases:0.35%
controls:0.19%
cases:2.30%
controls:1.18%
cases:4.95%
controls:2.38%
82
455
1921
19440
41
236
1970
19717
6
31
2005
19922
—
7
38
1967
19877
44
231
1873
19285
86
418
1650
17182
Other diseases of pharynx
J39.2 [45596281]
J39.2 [45596281]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.05%
—
—
—
—
—
—
6
8
1730
17592
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
5.4e-01
6.5e-01
9.5e-01
—
2.0e+00
2.1e-01
3.2e-01
cases:1.50%
controls:0.87%
cases:0.99%
controls:0.52%
cases:0.35%
controls:0.14%
—
—
cases:0.46%
controls:0.06%
cases:0.63%
controls:0.51%
cases:1.96%
controls:1.43%
30
174
1973
19721
20
104
1991
19849
7
27
2004
19926
—
9
12
1965
19903
12
99
1905
19417
34
251
1702
17349
Speech therapy
R4130 [2001310235]
R4130 [2001310235]
2.0e+00
1.1e+00
—
—
—
9.4e-01
5.5e-01
cases:0.45%
controls:0.06%
cases:0.25%
controls:0.08%
—
—
—
—
—
—
cases:0.26%
controls:0.10%
cases:0.46%
controls:0.27%
9
12
1994
19883
5
16
2006
19937
—
—
—
5
20
1912
19496
8
47
1728
17553
Endometriosis of uterus
N80.0 [45563025]
N80.0 [45563025]
2.0e+00
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.45%
controls:0.06%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
9
12
1994
19883
0
5
2011
19948
—
—
—
0
9
1917
19507
—
Physiologic investigation of micturition
XKD06 [2001306098]
XKD06 [2001306098]
5.5e-01
—
—
—
—
-1.0e+50
2.0e+00
cases:0.40%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.63%
controls:0.09%
8
46
1995
19849
—
—
—
—
0
10
1917
19506
11
15
1725
17585
Demanding adjuvant cytostatic therapy
WB123 [2001310631]
WB123 [2001310631]
2.0e+00
—
—
—
—
—
—
cases:0.30%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
1997
19887
—
—
—
—
—
—
Erythrocytes [#/volume] in Pleural fluid
26456-4 [3028308]
26456-4 [3028308]
2.0e+00
—
—
—
—
—
—
cases:0.30%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
1997
19887
—
—
—
—
—
—
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 [3018559]
18501-7 [3018559]
1.4e+00
2.0e+00
—
—
—
—
—
cases:0.40%
controls:0.10%
cases:0.30%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
8
20
1995
19875
6
8
2005
19945
—
—
—
—
—
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
3.3e-01
3.3e-01
7.0e-01
1.2e+00
3.5e-01
3.3e-01
3.3e-01
cases:30.10%
controls:23.72%
cases:16.81%
controls:12.72%
cases:4.67%
controls:2.39%
cases:0.25%
controls:0.08%
cases:3.14%
controls:2.23%
cases:17.68%
controls:13.42%
cases:37.62%
controls:30.15%
603
4719
1400
15176
338
2539
1673
17414
94
476
1917
19477
5
15
2006
19938
62
444
1912
19471
339
2620
1578
16896
653
5306
1083
12294
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
5.3e-01
6.8e-01
8.2e-01
—
2.0e+00
4.9e-02
1.3e-01
cases:1.80%
controls:1.07%
cases:1.24%
controls:0.64%
cases:0.40%
controls:0.18%
—
—
cases:0.56%
controls:0.08%
cases:0.68%
controls:0.65%
cases:2.25%
controls:1.98%
36
212
1967
19683
25
127
1986
19826
8
35
2003
19918
—
11
15
1963
19900
13
126
1904
19390
39
349
1697
17251
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
3.7e-01
4.2e-01
9.1e-01
—
1.6e+00
4.2e-01
4.4e-01
cases:4.34%
controls:3.03%
cases:2.19%
controls:1.45%
cases:0.50%
controls:0.20%
—
—
cases:0.81%
controls:0.17%
cases:2.24%
controls:1.49%
cases:5.70%
controls:3.76%
87
603
1916
19292
44
289
1967
19664
10
40
2001
19913
—
16
34
1958
19881
43
291
1874
19225
99
662
1637
16938
rizatriptan; oral
N02CC04 [21604379]
N02CC04 [21604379]
2.5e-01
6.6e-01
—
—
2.0e+00
7.6e-01
6.5e-01
cases:0.90%
controls:0.70%
cases:0.70%
controls:0.36%
—
—
—
—
cases:0.41%
controls:0.06%
cases:0.78%
controls:0.37%
cases:1.27%
controls:0.66%
18
140
1985
19755
14
72
1997
19881
—
—
8
11
1966
19904
15
72
1902
19444
22
117
1714
17483
Sampling
SPAT1263 [2001700364]
SPAT1263 [2001700364]
1.4e-01
2.2e-01
9.9e-01
—
9.9e-01
2.9e-01
2.9e-01
cases:7.09%
controls:6.19%
cases:3.13%
controls:2.53%
cases:1.04%
controls:0.39%
—
—
cases:0.96%
controls:0.36%
cases:2.97%
controls:2.24%
cases:9.04%
controls:6.93%
142
1232
1861
18663
63
505
1948
19448
21
78
1990
19875
—
19
72
1955
19843
57
438
1860
19078
157
1219
1579
16381
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
2.6e-01
4.9e-01
3.5e-01
—
6.8e-01
3.5e-01
4.3e-01
cases:8.79%
controls:6.91%
cases:6.61%
controls:4.14%
cases:1.34%
controls:0.95%
—
—
cases:1.62%
controls:0.83%
cases:5.89%
controls:4.23%
cases:14.17%
controls:9.70%
176
1374
1827
18521
133
826
1878
19127
27
190
1984
19763
—
32
165
1942
19750
113
825
1804
18691
246
1708
1490
15892
Simple examination of mouth
SAA01 [2001310274]
SAA01 [2001310274]
2.4e-01
3.1e-01
7.6e-01
-1.0e+50
3.6e-01
3.8e-01
2.6e-01
cases:17.97%
controls:14.75%
cases:8.95%
controls:6.72%
cases:1.64%
controls:0.77%
cases:0.00%
controls:0.04%
cases:1.27%
controls:0.88%
cases:10.12%
controls:7.12%
cases:24.19%
controls:19.78%
360
2935
1643
16960
180
1340
1831
18613
33
154
1978
19799
0
7
2011
19946
25
176
1949
19739
194
1390
1723
18126
420
3481
1316
14119
Intramuscular
ZX114 [2001311493]
ZX114 [2001311493]
4.1e-01
—
—
—
—
—
2.0e+00
cases:0.25%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.07%
5
33
1998
19862
—
—
—
—
—
9
13
1727
17587
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
5.2e-01
5.7e-01
1.2e+00
—
1.9e+00
3.8e-01
4.8e-01
cases:1.60%
controls:0.96%
cases:0.99%
controls:0.57%
cases:0.35%
controls:0.10%
—
—
cases:0.46%
controls:0.07%
cases:0.83%
controls:0.57%
cases:3.05%
controls:1.91%
32
191
1971
19704
20
113
1991
19840
7
20
2004
19933
—
9
13
1965
19902
16
112
1901
19404
53
336
1683
17264
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
2.5e-01
4.9e-01
3.4e-01
—
6.7e-01
3.5e-01
4.3e-01
cases:8.79%
controls:6.95%
cases:6.61%
controls:4.17%
cases:1.34%
controls:0.96%
—
—
cases:1.62%
controls:0.83%
cases:5.89%
controls:4.21%
cases:14.29%
controls:9.78%
176
1382
1827
18513
133
833
1878
19120
27
192
1984
19761
—
32
166
1942
19749
113
822
1804
18694
248
1721
1488
15879
Sacro-iliac joint MRI examination with high intensity magnet
NA6BG [2001307059]
NA6BG [2001307059]
1.9e+00
—
—
—
—
—
1.5e+00
cases:0.35%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.08%
7
10
1996
19885
—
—
—
—
—
6
14
1730
17586
Follitropin [Units/volume] in Serum or Plasma by Immunoassay
83098-4 [42529215]
83098-4 [42529215]
—
1.9e+00
—
—
—
—
6.5e-01
—
—
cases:0.35%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.21%
—
7
10
2004
19943
—
—
—
—
7
37
1729
17563
Acute inflammatory disease of uterus
N71.0 [45596880]
N71.0 [45596880]
7.7e-01
—
—
—
—
—
1.9e+00
cases:0.25%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.14%
5
23
1998
19872
—
—
—
—
—
16
24
1720
17576
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
4.3e-01
7.3e-01
—
—
1.9e+00
4.8e-01
5.7e-01
cases:2.15%
controls:1.40%
cases:0.99%
controls:0.48%
—
—
—
—
cases:0.41%
controls:0.06%
cases:0.68%
controls:0.42%
cases:2.36%
controls:1.35%
43
279
1960
19616
20
96
1991
19857
—
—
8
12
1966
19903
13
82
1904
19434
41
237
1695
17363
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
6.9e-01
5.7e-01
7.0e-01
—
2.1e-01
4.1e-01
6.5e-01
cases:5.14%
controls:2.65%
cases:2.73%
controls:1.57%
cases:0.85%
controls:0.42%
—
—
cases:0.51%
controls:0.41%
cases:2.30%
controls:1.53%
cases:4.61%
controls:2.47%
103
528
1900
19367
55
313
1956
19640
17
84
1994
19869
—
10
82
1964
19833
44
299
1873
19217
80
434
1656
17166
Other minor procedure in surgery of ear, nose and larynx
TDW99 [2001301879]
TDW99 [2001301879]
1.1e+00
1.9e+00
—
1.0e+50
—
—
7.1e-01
cases:0.60%
controls:0.20%
cases:0.40%
controls:0.06%
—
—
cases:0.75%
controls:0.00%
—
—
—
—
cases:0.58%
controls:0.28%
12
40
1991
19855
8
12
2003
19941
—
15
0
1996
19953
—
—
10
50
1726
17550
Inpatient Visit
IP [9201]
IP [9201]
3.4e-01
4.7e-01
1.1e+00
—
1.9e+00
2.5e-01
3.4e-01
cases:4.84%
controls:3.50%
cases:2.39%
controls:1.50%
cases:0.40%
controls:0.14%
—
—
cases:0.81%
controls:0.13%
cases:1.93%
controls:1.52%
cases:6.34%
controls:4.59%
97
697
1906
19198
48
299
1963
19654
8
27
2003
19926
—
16
25
1958
19890
37
296
1880
19220
110
807
1626
16793
Bordetella pertussis IgA Ab [Units/volume] in Serum
9362-5 [3025149]
9362-5 [3025149]
7.9e-01
-1.0e+50
—
—
—
—
1.9e+00
cases:0.30%
controls:0.14%
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.06%
6
27
1997
19868
0
7
2011
19946
—
—
—
—
7
11
1729
17589
aripiprazole; oral, parenteral
N05AX12 [21604562]
N05AX12 [21604562]
9.2e-01
7.1e-01
—
—
—
5.9e-01
9.5e-01
cases:1.00%
controls:0.40%
cases:0.60%
controls:0.30%
—
—
—
—
—
—
cases:0.57%
controls:0.32%
cases:1.09%
controls:0.43%
20
80
1983
19815
12
59
1999
19894
—
—
—
11
62
1906
19454
19
75
1717
17525
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
3.4e-01
-2.2e-01
—
1.0e+50
1.9e+00
5.2e-01
2.1e-01
cases:1.75%
controls:1.25%
cases:0.55%
controls:0.68%
—
—
cases:0.85%
controls:0.00%
cases:0.35%
controls:0.06%
cases:1.04%
controls:0.62%
cases:2.65%
controls:2.16%
35
248
1968
19647
11
136
2000
19817
—
17
0
1994
19953
7
11
1967
19904
20
121
1897
19395
46
381
1690
17219
Limited function/disability NOS
A28 [2002000162]
A28 [2002000162]
2.9e-01
6.5e-01
9.6e-01
1.2e+00
9.0e-01
4.1e-01
1.4e-01
cases:1.85%
controls:1.38%
cases:1.54%
controls:0.81%
cases:0.85%
controls:0.33%
cases:0.45%
controls:0.14%
cases:0.91%
controls:0.37%
cases:1.51%
controls:1.01%
cases:2.71%
controls:2.36%
37
275
1966
19620
31
161
1980
19792
17
65
1994
19888
9
28
2002
19925
18
74
1956
19841
29
197
1888
19319
47
415
1689
17185
combinations of corticosteroids
D07AB30 [21602118]
D07AB30 [21602118]
4.3e-01
4.4e-01
3.0e-01
—
-2.2e-03
5.0e-01
4.8e-01
cases:14.43%
controls:9.85%
cases:5.02%
controls:3.29%
cases:0.55%
controls:0.41%
—
—
cases:0.46%
controls:0.46%
cases:5.22%
controls:3.24%
cases:15.61%
controls:10.27%
289
1959
1714
17936
101
657
1910
19296
11
81
2000
19872
—
9
91
1965
19824
100
633
1817
18883
271
1807
1465
15793
combinations of corticosteroids
D07XB30 [21602188]
D07XB30 [21602188]
4.3e-01
4.4e-01
3.0e-01
—
-2.2e-03
5.0e-01
4.8e-01
cases:14.43%
controls:9.85%
cases:5.02%
controls:3.29%
cases:0.55%
controls:0.41%
—
—
cases:0.46%
controls:0.46%
cases:5.22%
controls:3.24%
cases:15.61%
controls:10.27%
289
1959
1714
17936
101
657
1910
19296
11
81
2000
19872
—
9
91
1965
19824
100
633
1817
18883
271
1807
1465
15793
Chronic respiratory failure
J96.1 [45557632]
J96.1 [45557632]
1.8e+00
1.6e+00
—
—
—
—
1.3e+00
cases:0.35%
controls:0.06%
cases:0.35%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.18%
7
11
1996
19884
7
14
2004
19939
—
—
—
—
11
32
1725
17568
Chloride [Moles/volume] in Blood
2069-3 [3018572]
2069-3 [3018572]
1.0e+00
1.8e+00
—
1.0e+50
—
—
2.2e-01
cases:0.60%
controls:0.22%
cases:0.35%
controls:0.06%
—
—
cases:0.35%
controls:0.00%
—
—
—
—
cases:0.35%
controls:0.28%
12
43
1991
19852
7
11
2004
19942
—
7
0
2004
19953
—
—
6
49
1730
17551
Anion gap in Blood by calculation
41276-7 [3039000]
41276-7 [3039000]
1.0e+00
1.8e+00
—
1.0e+50
—
—
2.2e-01
cases:0.60%
controls:0.22%
cases:0.35%
controls:0.06%
—
—
cases:0.35%
controls:0.00%
—
—
—
—
cases:0.35%
controls:0.28%
12
43
1991
19852
7
11
2004
19942
—
7
0
2004
19953
—
—
6
49
1730
17551
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
5.8e-01
6.2e-01
1.7e-01
—
9.3e-01
4.4e-01
6.3e-01
cases:5.09%
controls:2.92%
cases:2.59%
controls:1.40%
cases:0.30%
controls:0.25%
—
—
cases:0.66%
controls:0.26%
cases:2.30%
controls:1.50%
cases:6.28%
controls:3.44%
102
580
1901
19315
52
280
1959
19673
6
50
2005
19903
—
13
52
1961
19863
44
292
1873
19224
109
605
1627
16995
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
2.4e-01
8.0e-02
8.7e-01
—
6.9e-01
4.0e-01
3.2e-01
cases:15.58%
controls:12.69%
cases:5.52%
controls:5.12%
cases:1.24%
controls:0.53%
—
—
cases:1.17%
controls:0.59%
cases:7.56%
controls:5.19%
cases:20.68%
controls:15.94%
312
2525
1691
17370
111
1021
1900
18932
25
105
1986
19848
—
23
117
1951
19798
145
1013
1772
18503
359
2805
1377
14795
Orthopedic Surgery
20 [38004465]
20 [38004465]
4.7e-01
4.9e-01
4.5e-01
—
3.2e-01
3.9e-01
4.6e-01
cases:16.28%
controls:10.79%
cases:6.36%
controls:4.01%
cases:1.04%
controls:0.67%
—
—
cases:0.86%
controls:0.63%
cases:6.21%
controls:4.27%
cases:18.66%
controls:12.62%
326
2147
1677
17748
128
801
1883
19152
21
133
1990
19820
—
17
125
1957
19790
119
834
1798
18682
324
2221
1412
15379
lactulose; oral
A06AD11 [21600571]
A06AD11 [21600571]
8.4e-01
9.7e-01
8.4e-01
—
1.1e+00
6.7e-01
4.6e-01
cases:3.05%
controls:1.34%
cases:1.59%
controls:0.61%
cases:0.35%
controls:0.15%
—
—
cases:0.51%
controls:0.17%
cases:1.36%
controls:0.70%
cases:2.53%
controls:1.62%
61
266
1942
19629
32
121
1979
19832
7
30
2004
19923
—
10
34
1964
19881
26
137
1891
19379
44
285
1692
17315
Puncture of maxillary antrum
TDM10 [2001301819]
TDM10 [2001301819]
5.3e-01
—
—
—
—
1.8e+00
8.3e-01
cases:0.40%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.08%
cases:0.63%
controls:0.28%
8
47
1995
19848
—
—
—
—
9
15
1908
19501
11
49
1725
17551
Lesion of plantar nerve
G57.6 [45586306]
G57.6 [45586306]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.09%
—
—
—
—
—
—
9
15
1727
17585
clarithromycin; oral, parenteral
J01FA09 [21602977]
J01FA09 [21602977]
4.7e-01
7.1e-01
1.4e+00
—
—
3.8e-01
6.1e-01
cases:5.54%
controls:3.52%
cases:1.79%
controls:0.89%
cases:0.40%
controls:0.10%
—
—
—
—
cases:1.36%
controls:0.93%
cases:6.68%
controls:3.74%
111
701
1892
19194
36
177
1975
19776
8
20
2003
19933
—
—
26
182
1891
19334
116
658
1620
16942
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
3.7e-01
2.6e-01
—
1.0e+50
1.1e+00
8.9e-01
5.4e-01
cases:6.59%
controls:4.65%
cases:1.84%
controls:1.43%
—
—
cases:0.35%
controls:0.00%
cases:0.35%
controls:0.12%
cases:2.71%
controls:1.13%
cases:6.11%
controls:3.66%
132
926
1871
18969
37
285
1974
19668
—
7
0
2004
19953
7
24
1967
19891
52
221
1865
19295
106
644
1630
16956
Extensive high resolution CT examination of lungs
GD1ED [2001303637]
GD1ED [2001303637]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.07%
—
—
—
—
—
—
7
12
1729
17588
Bordetella pertussis Ab [Titer] in Serum
22116-8 [3025018]
22116-8 [3025018]
6.5e-01
-1.0e+50
—
—
—
—
1.8e+00
cases:0.25%
controls:0.13%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.07%
5
26
1998
19869
0
5
2011
19948
—
—
—
—
7
12
1729
17588
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
6.6e-01
4.3e-01
—
—
—
1.1e+00
5.4e-01
cases:1.65%
controls:0.86%
cases:0.55%
controls:0.36%
—
—
—
—
—
—
cases:0.73%
controls:0.24%
cases:1.61%
controls:0.95%
33
171
1970
19724
11
71
2000
19882
—
—
—
14
47
1903
19469
28
167
1708
17433
Shoulder ultrasound examination
NB1AE [2001307227]
NB1AE [2001307227]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.08%
—
0
7
2011
19946
—
—
—
—
8
14
1728
17586
Persistent somatoform pain disorder
F45.4 [45605498]
F45.4 [45605498]
1.2e+00
-1.0e+50
—
—
—
—
1.8e+00
cases:0.25%
controls:0.08%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.08%
5
15
1998
19880
0
6
2011
19947
—
—
—
—
8
14
1728
17586
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
2.7e-01
4.3e-01
6.2e-01
—
1.0e+00
2.3e-01
3.1e-01
cases:8.14%
controls:6.36%
cases:5.82%
controls:3.86%
cases:1.34%
controls:0.73%
—
—
cases:1.57%
controls:0.57%
cases:4.64%
controls:3.73%
cases:11.87%
controls:8.98%
163
1265
1840
18630
117
771
1894
19182
27
145
1984
19808
—
31
114
1943
19801
89
728
1828
18788
206
1581
1530
16019
Application of heat
ZXC60 [2001311371]
ZXC60 [2001311371]
1.8e+00
—
—
—
—
—
—
cases:0.35%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
7
12
1996
19883
—
—
—
—
—
—
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
4.0e-01
5.4e-01
1.1e+00
—
1.8e+00
-1.9e-03
7.6e-02
cases:1.40%
controls:0.94%
cases:0.90%
controls:0.52%
cases:0.35%
controls:0.12%
—
—
cases:0.41%
controls:0.07%
cases:0.52%
controls:0.52%
cases:1.84%
controls:1.71%
28
187
1975
19708
18
104
1993
19849
7
24
2004
19929
—
8
14
1966
19901
10
102
1907
19414
32
301
1704
17299
carbamazepine; oral, rectal
N03AF01 [21604417]
N03AF01 [21604417]
8.7e-01
5.3e-01
1.1e+00
—
1.2e+00
8.8e-01
5.4e-01
cases:1.60%
controls:0.68%
cases:0.75%
controls:0.44%
cases:0.25%
controls:0.08%
—
—
cases:0.46%
controls:0.14%
cases:0.99%
controls:0.42%
cases:0.98%
controls:0.57%
32
135
1971
19760
15
88
1996
19865
5
16
2006
19937
—
9
27
1965
19888
19
81
1898
19435
17
101
1719
17499
melatonin; oral
N05CH01 [21604659]
N05CH01 [21604659]
6.5e-01
5.5e-01
8.3e-01
—
5.2e-01
6.4e-01
4.5e-01
cases:3.00%
controls:1.58%
cases:1.74%
controls:1.01%
cases:0.75%
controls:0.33%
—
—
cases:0.51%
controls:0.30%
cases:2.19%
controls:1.17%
cases:4.26%
controls:2.77%
60
315
1943
19580
35
202
1976
19751
15
65
1996
19888
—
10
60
1964
19855
42
228
1875
19288
74
488
1662
17112
Other migraine
G43.8 [45595941]
G43.8 [45595941]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.11%
—
—
—
—
—
—
11
20
1725
17580
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
ZXE13 [2001311404]
7.1e-02
—
-1.0e+50
—
—
—
1.7e+00
cases:0.40%
controls:0.37%
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.63%
controls:0.11%
8
74
1995
19821
—
0
6
2011
19947
—
—
—
11
20
1725
17580
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
8.8e-01
8.2e-01
5.9e-01
—
9.0e-01
4.5e-01
3.3e-01
cases:2.00%
controls:0.83%
cases:1.19%
controls:0.53%
cases:0.40%
controls:0.22%
—
—
cases:0.51%
controls:0.21%
cases:1.15%
controls:0.74%
cases:2.48%
controls:1.80%
40
166
1963
19729
24
106
1987
19847
8
44
2003
19909
—
10
41
1964
19874
22
144
1895
19372
43
316
1693
17284
Functional endoscopic opening of maxillary antrum
DMB20 [2001301780]
DMB20 [2001301780]
9.1e-01
1.3e+00
—
—
—
1.7e+00
3.9e-01
cases:0.65%
controls:0.26%
cases:0.40%
controls:0.11%
—
—
—
—
—
—
cases:0.42%
controls:0.08%
cases:0.46%
controls:0.31%
13
52
1990
19843
8
21
2003
19932
—
—
—
8
15
1909
19501
8
55
1728
17545
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
5.2e-01
6.1e-01
5.5e-01
-1.0e+50
7.4e-01
4.3e-01
5.7e-01
cases:6.49%
controls:3.98%
cases:3.83%
controls:2.11%
cases:1.14%
controls:0.66%
cases:0.00%
controls:0.03%
cases:1.06%
controls:0.51%
cases:3.39%
controls:2.23%
cases:7.49%
controls:4.39%
130
792
1873
19103
77
422
1934
19531
23
132
1988
19821
0
6
2011
19947
21
102
1953
19813
65
436
1852
19080
130
772
1606
16828
Glaucoma secondary to other eye disorders
H40.5 [45571978]
H40.5 [45571978]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.09%
—
—
—
—
—
—
8
15
1728
17585
Post-traumatic stress disorder
F43.1 [45595909]
F43.1 [45595909]
5.3e-01
1.0e+00
—
—
—
1.7e+00
4.3e-01
cases:0.35%
controls:0.21%
cases:0.25%
controls:0.09%
—
—
—
—
—
—
cases:0.47%
controls:0.09%
cases:0.40%
controls:0.26%
7
41
1996
19854
5
18
2006
19935
—
—
—
9
17
1908
19499
7
46
1729
17554
Mixed anxiety and depressive disorder
F41.2 [45566845]
F41.2 [45566845]
5.0e-01
1.1e+00
—
—
—
6.4e-01
6.2e-01
cases:1.20%
controls:0.73%
cases:0.80%
controls:0.28%
—
—
—
—
—
—
cases:0.57%
controls:0.30%
cases:2.07%
controls:1.13%
24
145
1979
19750
16
55
1995
19898
—
—
—
11
59
1906
19457
36
199
1700
17401
Acute maxillary sinusitis
J01.0 [45601112]
J01.0 [45601112]
4.4e-01
5.6e-01
1.5e+00
—
9.3e-01
6.4e-01
6.0e-01
cases:3.74%
controls:2.45%
cases:1.59%
controls:0.92%
cases:0.35%
controls:0.08%
—
—
cases:0.25%
controls:0.10%
cases:1.72%
controls:0.91%
cases:5.65%
controls:3.18%
75
487
1928
19408
32
183
1979
19770
7
16
2004
19937
—
5
20
1969
19895
33
178
1884
19338
98
560
1638
17040
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
M01AC06 [21603965]
5.2e-01
5.3e-01
3.3e-01
—
4.7e-01
7.1e-01
4.5e-01
cases:6.84%
controls:4.19%
cases:2.09%
controls:1.24%
cases:0.30%
controls:0.22%
—
—
cases:0.30%
controls:0.19%
cases:2.92%
controls:1.46%
cases:7.55%
controls:4.93%
137
834
1866
19061
42
248
1969
19705
6
43
2005
19910
—
6
38
1968
19877
56
285
1861
19231
131
868
1605
16732
Headache
R51 [45558474]
R51 [45558474]
6.5e-01
—
—
—
—
1.7e+00
8.6e-01
cases:0.70%
controls:0.37%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.12%
cases:0.98%
controls:0.41%
14
73
1989
19822
—
—
—
—
12
23
1905
19493
17
73
1719
17527
Other orthopedic bandage, unspecified region
TNX39 [2001308566]
TNX39 [2001308566]
1.7e+00
—
—
—
—
—
—
cases:0.40%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
8
15
1995
19880
—
—
—
—
—
—
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
6.9e-01
9.4e-01
—
—
—
7.0e-01
5.4e-01
cases:1.70%
controls:0.85%
cases:0.85%
controls:0.33%
—
—
—
—
—
—
cases:0.63%
controls:0.31%
cases:1.79%
controls:1.05%
34
170
1969
19725
17
66
1994
19887
—
—
—
12
61
1905
19455
31
185
1705
17415
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
5.1e-01
4.5e-01
2.6e-01
—
3.8e-01
5.6e-01
5.6e-01
cases:4.64%
controls:2.84%
cases:2.24%
controls:1.43%
cases:0.55%
controls:0.42%
—
—
cases:0.66%
controls:0.45%
cases:2.45%
controls:1.41%
cases:5.59%
controls:3.26%
93
565
1910
19330
45
286
1966
19667
11
84
2000
19869
—
13
90
1961
19825
47
276
1870
19240
97
574
1639
17026
Neonatal screening
60151004 [4246502]
60151004 [4246502]
-2.3e-02
—
—
—
—
—
1.6e+00
cases:0.30%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.09%
6
61
1997
19834
—
—
—
—
—
8
16
1728
17584
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
2.5e-01
1.1e-01
—
1.0e+50
1.6e+00
5.7e-01
3.8e-01
cases:3.25%
controls:2.54%
cases:1.29%
controls:1.16%
—
—
cases:0.85%
controls:0.00%
cases:0.76%
controls:0.15%
cases:1.88%
controls:1.07%
cases:4.67%
controls:3.24%
65
505
1938
19390
26
232
1985
19721
—
17
0
1994
19953
15
30
1959
19885
36
208
1881
19308
81
570
1655
17030
terbutaline; inhalant
R03AC03 [21603257]
R03AC03 [21603257]
4.5e-01
6.1e-01
3.2e-01
—
—
3.9e-01
5.6e-01
cases:3.59%
controls:2.33%
cases:1.89%
controls:1.03%
cases:0.25%
controls:0.18%
—
—
—
—
cases:1.51%
controls:1.02%
cases:3.92%
controls:2.27%
72
463
1931
19432
38
206
1973
19747
5
36
2006
19917
—
—
29
200
1888
19316
68
400
1668
17200
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
4.8e-01
6.1e-01
1.2e+00
—
—
5.3e-01
5.2e-01
cases:3.15%
controls:1.96%
cases:1.89%
controls:1.03%
cases:0.35%
controls:0.11%
—
—
—
—
cases:1.83%
controls:1.08%
cases:4.84%
controls:2.93%
63
390
1940
19505
38
206
1973
19747
7
22
2004
19931
—
—
35
211
1882
19305
84
515
1652
17085
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
3.6e-01
4.5e-01
4.2e-01
—
6.2e-01
3.9e-01
4.2e-01
cases:12.83%
controls:9.33%
cases:5.57%
controls:3.63%
cases:0.99%
controls:0.66%
—
—
cases:1.01%
controls:0.55%
cases:5.69%
controls:3.93%
cases:15.84%
controls:11.02%
257
1856
1746
18039
112
725
1899
19228
20
131
1991
19822
—
20
109
1954
19806
109
767
1808
18749
275
1940
1461
15660
Vacuum aspiration of products of conception from uterus
LCH00 [2001306620]
LCH00 [2001306620]
1.6e+00
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.40%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.00%
controls:0.05%
8
16
1995
19879
—
—
—
—
0
6
1917
19510
0
9
1736
17591
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
8.3e-01
1.6e+00
—
—
—
—
8.5e-01
cases:0.70%
controls:0.31%
cases:0.50%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.35%
14
61
1989
19834
10
20
2001
19933
—
—
—
—
14
61
1722
17539
Allergy, unspecified
T78.4 [45580373]
T78.4 [45580373]
6.2e-01
1.6e+00
—
—
—
—
9.9e-01
cases:0.70%
controls:0.38%
cases:0.40%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.30%
14
75
1989
19820
8
16
2003
19937
—
—
—
—
14
53
1722
17547
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
3.2e-01
2.6e-01
7.0e-01
—
1.3e+00
2.5e-01
2.2e-01
cases:11.08%
controls:8.32%
cases:3.68%
controls:2.87%
cases:0.75%
controls:0.37%
—
—
cases:1.42%
controls:0.40%
cases:3.70%
controls:2.90%
cases:9.79%
controls:7.99%
222
1656
1781
18239
74
573
1937
19380
15
74
1996
19879
—
28
79
1946
19836
71
565
1846
18951
170
1407
1566
16193
mupirocin; nasal
R01AX06 [21603201]
R01AX06 [21603201]
1.2e-01
—
—
—
—
1.6e+00
9.2e-01
cases:0.30%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.12%
cases:0.81%
controls:0.32%
6
53
1997
19842
—
—
—
—
11
23
1906
19493
14
57
1722
17543
Shortness of breath/dyspnoea
R02 [2002000883]
R02 [2002000883]
6.8e-01
6.8e-01
—
—
—
2.6e-01
8.9e-01
cases:1.85%
controls:0.94%
cases:0.75%
controls:0.38%
—
—
—
—
—
—
cases:0.47%
controls:0.36%
cases:3.17%
controls:1.32%
37
187
1966
19708
15
76
1996
19877
—
—
—
9
71
1908
19445
55
233
1681
17367
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.6e-01
3.5e-01
3.1e-01
—
6.8e-01
2.7e-01
2.8e-01
cases:13.23%
controls:10.52%
cases:7.76%
controls:5.61%
cases:1.19%
controls:0.88%
—
—
cases:1.57%
controls:0.80%
cases:7.09%
controls:5.50%
cases:18.03%
controls:14.23%
265
2092
1738
17803
156
1119
1855
18834
24
176
1987
19777
—
31
160
1943
19755
136
1073
1781
18443
313
2505
1423
15095
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
2.5e-01
4.8e-01
3.1e-01
—
6.6e-01
3.4e-01
4.3e-01
cases:9.04%
controls:7.21%
cases:6.76%
controls:4.30%
cases:1.34%
controls:0.99%
—
—
cases:1.62%
controls:0.85%
cases:6.00%
controls:4.35%
cases:14.80%
controls:10.18%
181
1434
1822
18461
136
857
1875
19096
27
198
1984
19755
—
32
169
1942
19746
115
848
1802
18668
257
1792
1479
15808
clobetasol
D07AD01 [21602141]
D07AD01 [21602141]
3.8e-01
5.1e-01
—
—
—
8.7e-01
6.9e-01
cases:2.50%
controls:1.72%
cases:1.24%
controls:0.75%
—
—
—
—
—
—
cases:1.62%
controls:0.68%
cases:3.97%
controls:2.04%
50
342
1953
19553
25
150
1986
19803
—
—
—
31
133
1886
19383
69
359
1667
17241
No procedures
SPAT1301 [2001700402]
SPAT1301 [2001700402]
8.7e-02
2.7e-01
2.7e-01
1.6e+00
7.4e-02
3.0e-01
3.3e-01
cases:4.74%
controls:4.36%
cases:1.89%
controls:1.45%
cases:0.50%
controls:0.38%
cases:0.45%
controls:0.10%
cases:0.41%
controls:0.38%
cases:2.03%
controls:1.52%
cases:6.28%
controls:4.58%
95
868
1908
19027
38
289
1973
19664
10
76
2001
19877
9
19
2002
19934
8
75
1966
19840
39
297
1878
19219
109
806
1627
16794
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
M01AE03 [21603969]
4.9e-01
4.9e-01
6.5e-01
—
1.0e+00
5.9e-01
4.6e-01
cases:8.99%
controls:5.69%
cases:2.44%
controls:1.51%
cases:0.30%
controls:0.16%
—
—
cases:0.51%
controls:0.18%
cases:2.30%
controls:1.29%
cases:5.47%
controls:3.52%
180
1133
1823
18762
49
301
1962
19652
6
31
2005
19922
—
10
36
1964
19879
44
251
1873
19265
95
619
1641
16981
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
4.2e-01
3.7e-01
5.1e-01
—
6.4e-01
5.8e-01
5.5e-01
cases:9.24%
controls:6.29%
cases:3.93%
controls:2.76%
cases:0.70%
controls:0.42%
—
—
cases:0.71%
controls:0.38%
cases:4.33%
controls:2.48%
cases:11.35%
controls:6.88%
185
1252
1818
18643
79
550
1932
19403
14
84
1997
19869
—
14
75
1960
19840
83
484
1834
19032
197
1210
1539
16390
Difficulties in perfomrming procedure
ZXD30 [2001311389]
ZXD30 [2001311389]
5.8e-02
—
—
—
-1.0e+50
—
1.5e+00
cases:0.40%
controls:0.38%
—
—
—
—
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.86%
controls:0.19%
8
75
1995
19820
—
—
—
0
5
1974
19910
—
15
33
1721
17567
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1560
13676
1.51
15.72
4.7
4.4
11.39
11.47
mm/h
0.08
1479
12830
1306
11062
1.46
15.60
10.0
9.7
4.04
4.04
e9/l
0.04
1145
9590
1214
10150
1.45
15.48
7.2
6.7
1.97
1.96
e9/l
0.11
1084
8959
1416
12191
1.47
15.47
5.3
4.6
90.42
1843.94
e6/l
2.76
12
166
1222
10237
1.45
15.36
7.5
6.9
0.19
0.19
e9/l
0.49
1078
8949
1456
12684
1.46
14.33
3.7
3.3
—
—
—
0
0
1575
13966
1.48
13.84
8.7
8.1
78.00
79.84
u/l
0.90
1500
13306
1112
9268
1.41
13.68
7.3
7.7
1.22
1.21
mmol/l
0.50
975
8103
561
4180
1.46
12.59
2.0
1.9
0.90
1.20
mg/l
2.59
412
3172
201
1178
1.78
12.39
1.3
1.3
84.27
47.76
au/ml
1.29
12
81
576
4328
1.45
12.33
1.5
1.5
2.20
2.29
g/l
0.47
342
2699
1004
8331
1.38
12.10
7.0
7.2
1.21
1.21
mmol/l
0.25
926
7745
965
7982
1.38
11.73
2.3
2.1
96.42
96.56
pmol/l
0.03
521
4278
212
1287
1.72
11.54
2.5
2.4
28.00
19.83
au/ml
0.86
27
132
975
8096
1.37
11.49
5.3
5.2
36.24
35.99
g/l
0.73
907
7638
729
5788
1.39
11.24
2.7
2.6
53.30
73.92
u/l
0.86
672
5378
1125
9579
1.37
11.21
6.4
6.6
10.69
11.93
umol/l
3.18
1073
9132
960
8030
1.35
10.45
14.2
14.3
1.18
1.24
inr
2.51
792
6693
1023
8642
1.35
10.43
2.7
2.6
76.10
76.02
nmol/l
0.03
930
7927
631
4955
1.39
10.18
1.5
1.4
2.91
1.79
u/ml
0.57
162
1336
447
3305
1.44
10.17
3.0
3.0
1.03
1.09
e6/l
0.14
228
1737
396
2869
1.47
10.01
1.8
1.7
1092.23
1172.51
nmol/l
1.03
294
2199
809
6631
1.35
9.90
4.0
3.7
39.15
68.11
ng/l
0.92
540
4450
662
5296
1.36
9.37
3.7
3.3
0.38
0.42
e6/l
0.19
488
3863
80
378
2.16
9.29
1.6
1.3
—
—
—
0
0
80
378
2.16
9.29
1.6
1.3
—
—
—
0
0
637
5096
1.35
8.93
2.4
2.4
2.65
2.80
mg/l
1.06
542
4407
1933
18285
1.56
8.81
19.3
15.3
22.25
23.30
mg/l
0.76
1622
14913
410
3069
1.41
8.58
3.1
3.2
2.86
2.68
e6/l
0.14
188
1495
413
3101
1.41
8.48
2.2
1.9
—
—
—
0
0
675
5485
1.34
8.44
2.7
2.2
172.49
214.66
u/l
0.94
637
5226
770
6380
1.32
8.39
3.1
3.4
2.35
2.36
mmol/l
0.76
692
5855
1598
14650
1.35
8.34
5.1
4.4
14.72
14.71
pmol/l
0.10
1468
13524
739
6098
1.32
8.26
3.7
3.5
21.96
69.42
e6/l
3.34
563
4644
210
1385
1.57
8.22
1.5
1.5
—
—
—
0
0
1134
9967
1.29
7.74
4.0
3.8
0.00
0.00
estimate
0.50
189
2119
1149
10127
1.29
7.63
4.1
3.9
0.04
0.16
estimate
0.35
180
2030
1142
10073
1.28
7.47
4.0
3.9
8.29
3.80
estimate
0.23
192
2153
319
2340
1.43
7.41
2.2
1.8
—
—
—
0
0
174
1128
1.59
7.34
1.8
1.7
—
—
—
0
0
1089
9562
1.28
7.32
3.5
3.2
122.66
108.29
ug/l
0.46
1010
8997
212
1439
1.52
7.30
1.4
1.3
223.15
279.17
u/ml
0.30
200
1337
588
4768
1.32
7.26
4.9
4.3
91.61
90.08
%
0.83
576
4663
671
5542
1.31
7.25
3.1
3.0
0.00
0.03
0.74
17
105
95
526
1.84
7.13
1.1
1.2
—
—
—
0
0
1811
17050
1.39
7.12
6.4
5.4
1.83
1.88
mu/l
0.72
1694
15936
440
3447
1.35
6.83
5.0
3.8
189.83
533.52
ng/l
3.57
318
2557
1391
12651
1.28
6.80
3.9
3.3
42.60
45.42
u/l
0.76
1314
12006
93
524
1.81
6.62
1.1
1.1
—
—
—
0
0
1921
18323
1.45
6.55
21.6
17.9
3.95
3.96
mmol/l
0.51
1887
17923
361
2760
1.37
6.54
2.6
2.6
148.46
118.73
ug/g
0.48
287
2220
255
1837
1.44
6.52
2.5
2.4
37.11
65.56
u/l
0.53
222
1551
263
1906
1.43
6.51
6.0
6.8
—
—
—
0
0
450
3564
1.33
6.46
2.8
2.9
2.44
2.44
mmol/l
0.78
400
3216
1917
18289
1.44
6.42
21.4
17.7
139.65
139.63
mmol/l
0.11
1890
17930
404
3158
1.34
6.33
2.4
2.6
13.28
13.28
umol/l
0.00
371
2954
195
1341
1.50
6.32
1.7
1.7
—
—
—
0
0
623
5181
1.28
6.21
1.7
1.7
20.99
20.25
nmol/l
0.63
542
4454
350
2705
1.35
5.88
2.3
2.7
22.56
22.84
%
0.15
323
2531
1207
10889
1.25
5.86
5.9
5.4
6.59
6.60
mmol/l
0.04
1154
10268
512
4184
1.29
5.79
3.0
2.7
6.57
6.29
e6/l
0.15
466
3817
557
4603
1.28
5.77
2.9
2.8
333.18
337.99
umol/l
0.51
494
4102
601
5037
1.27
5.51
3.4
3.3
1095.06
1237.92
ng/l
0.51
504
4283
294
2239
1.36
5.42
2.2
1.8
—
—
—
0
0
555
4625
1.27
5.31
2.5
2.5
—
—
—
0
0
390
3115
1.31
5.19
3.9
3.9
0.82
0.82
mmol/l
0.19
364
2953
172
1216
1.45
4.89
3.8
3.5
4.53
4.56
pmol/l
0.15
156
1087
1988
19227
1.44
4.86
23.2
19.3
73.22
74.98
umol/l
2.65
1970
19014
247
1863
1.37
4.84
2.6
2.2
—
—
—
0
0
183
1312
1.43
4.83
4.5
3.0
129.76
195.74
ng/l
2.23
161
1194
82
496
1.68
4.65
4.5
3.3
2.02
2.05
index
0.02
57
267
367
2951
1.29
4.62
2.3
2.6
2.37
2.34
g/l
0.40
338
2748
188
1370
1.41
4.54
4.5
4.7
5.10
5.13
kpa
0.27
181
1329
113
746
1.54
4.50
1.7
1.7
—
—
—
0
0
255
1956
1.34
4.49
2.5
2.2
367.13
382.41
nmol/l
0.63
233
1810
136
936
1.48
4.45
1.6
1.4
—
—
—
0
0
406
3328
1.27
4.38
1.3
1.3
10.49
11.78
u/ml
0.06
141
1290
167
1207
1.42
4.24
4.1
4.7
1.74
1.58
mmol/l
0.23
124
893
1971
19091
1.38
4.22
13.4
11.7
25.97
25.89
u/l
0.07
1924
18600
153
1091
1.43
4.18
1.3
1.4
—
—
—
0
0
210
1591
1.35
4.02
2.5
2.1
—
—
—
0
0
428
3568
1.25
3.97
1.3
1.3
30.33
29.88
iu/ml
0.03
113
1077
10
18
5.58
3.97
1.9
1.9
51.00
46.33
umol/l
—
10
18
1660
15771
1.23
3.90
23.7
19.3
332.72
332.61
g/l
0.18
1649
15672
967
8750
1.19
3.87
2.8
2.8
—
—
estimate
—
0
0
25
107
2.35
3.83
3.1
3.0
509.88
1140.73
u/ml
1.63
25
107
34
166
2.06
3.81
3.6
4.3
—
—
—
0
0
86
562
1.55
3.64
1.2
1.3
—
—
—
0
0
276
2207
1.29
3.62
3.6
3.0
5.83
7.78
umol/l
2.23
243
1930
107
740
1.47
3.48
1.5
1.7
20.37
11.68
u/ml
0.72
21
183
2044
19993
1.44
3.43
28.3
23.2
255.06
254.35
e9/l
0.19
2018
19615
85
562
1.53
3.43
1.4
1.4
303.69
287.94
ug/g
0.26
39
329
1725
16517
1.22
3.41
6.8
6.0
38.57
38.76
mmol/mol
0.44
1627
15563
25
113
2.23
3.41
6.6
3.9
0.88
0.83
index
0.13
25
113
52
305
1.72
3.39
1.7
1.5
—
—
—
0
0
145
1066
1.39
3.38
7.7
7.4
25.01
24.39
mmol/l
1.24
138
1021
2045
20009
1.44
3.38
28.5
23.3
134.88
135.08
g/l
0.26
2032
19825
2044
19998
1.44
3.37
28.2
23.1
90.37
90.60
fl
1.50
2029
19812
1776
17064
1.23
3.36
17.0
14.6
86.35
84.58
ml/min/173m2
2.77
1638
15595
117
830
1.43
3.34
5.1
5.4
24.50
24.62
mmol/l
0.24
112
794
2044
20001
1.43
3.34
28.3
23.1
4.51
4.50
e12/l
0.05
2007
19576
2044
20002
1.43
3.33
28.9
23.7
40.18
40.48
%
0.84
2029
19804
97
665
1.48
3.31
2.3
2.0
—
—
—
0
0
519
4493
1.20
3.30
4.2
3.9
1.02
1.36
kg/l
0.50
332
2982
40
219
1.84
3.28
1.5
1.4
—
—
—
0
0
89
601
1.50
3.27
2.1
1.9
—
—
—
0
0
2044
20007
1.43
3.27
28.4
23.2
6.72
6.73
e9/l
0.07
2006
19574
39
213
1.85
3.23
1.5
1.5
—
—
—
0
0
39
213
1.85
3.23
1.5
1.5
—
—
—
0
0
40
221
1.83
3.19
1.5
1.4
—
—
—
0
0
39
214
1.84
3.18
1.5
1.5
—
—
—
0
0
26
125
2.09
3.08
1.7
1.6
5.28
7.21
ug/l
0.96
26
110
721
6457
1.18
3.08
3.7
3.3
29.15
32.87
u/l
2.74
682
6129
7
12
5.85
3.02
7.1
6.6
—
—
—
0
0
38
211
1.82
3.00
1.4
1.7
67.50
59.22
%
0.59
24
134
21
94
2.25
2.96
1.1
1.7
—
—
—
0
0
21
94
2.25
2.96
1.1
1.7
—
—
—
0
0
21
94
2.25
2.96
1.1
1.7
—
—
—
0
0
21
94
2.25
2.96
1.1
1.7
—
—
—
0
0
176
1365
1.32
2.93
2.8
2.5
5.25
7.66
ug/l
1.10
154
1219
216
1722
1.28
2.92
5.8
8.2
8.05
9.16
mmol/l
1.98
207
1666
254
2066
1.26
2.92
8.5
9.2
5.23
5.10
kpa
1.06
240
1997
336
2820
1.23
2.91
2.4
2.4
29.67
29.54
s
0.12
325
2739
254
2067
1.26
2.91
8.4
9.2
12.29
12.47
kpa
0.19
241
2000
151
1153
1.33
2.81
1.1
1.1
—
—
—
0
0
827
7543
1.16
2.71
3.9
3.7
0.18
0.09
estimate
0.23
153
1764
29
153
1.91
2.70
1.3
1.1
117.93
109.73
pmol/l
0.27
29
153
244
1998
1.25
2.66
4.4
4.6
1.94
1.71
mmol/l
0.45
218
1692
310
2605
1.22
2.66
6.1
6.5
1.03
1.07
mmol/l
1.81
290
2419
38
220
1.74
2.65
1.5
1.4
—
—
—
0
0
1764
17032
1.20
2.65
5.6
4.8
5.83
5.86
mmol/l
0.59
1621
15740
297
2486
1.23
2.64
1.9
1.8
1.45
1.46
%
0.16
265
2182
1827
17705
1.21
2.60
6.0
5.4
2.70
2.71
mmol/l
0.11
1722
16614
251
2073
1.24
2.54
5.4
4.6
33.23
32.40
%
0.55
171
1429
248
2048
1.24
2.51
8.5
9.2
1.44
0.91
mmol/l
1.61
208
1699
17
75
2.28
2.51
1.0
1.2
101.33
89.39
%
—
9
44
90
645
1.41
2.51
2.8
3.0
25.04
24.65
mmol/l
0.44
90
635
825
7561
1.15
2.48
2.0
1.9
1.34
1.36
mmol/l
0.32
712
6495
106
783
1.37
2.48
5.4
5.8
1.55
1.56
%
0.05
99
741
180
1437
1.28
2.44
3.8
4.4
73.29
85.30
ng/l
1.26
151
1275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
556
1.44
2.44
2.5
3.9
0.42
0.35
iu/ml
0.64
43
297
96
700
1.39
2.43
1.8
1.6
12.28
9.03
u/l
1.31
79
542
325
2773
1.20
2.39
2.4
2.3
—
—
—
0
0
248
2060
1.23
2.39
4.4
4.6
5.83
5.82
kpa
0.05
240
2004
30
168
1.80
2.37
6.2
3.7
12.48
13.39
index
0.29
25
113
215
1761
1.25
2.36
3.9
4.2
4.68
4.62
kpa
0.21
206
1714
84
602
1.41
2.36
2.4
2.7
—
—
—
0
0
184
1482
1.26
2.33
2.4
2.3
11.08
12.68
nmol/l
1.74
161
1355
36
215
1.69
2.29
1.1
1.1
—
—
—
0
0
184
1486
1.26
2.29
1.3
1.2
78.43
141.46
u/ml
3.84
74
574
224
1853
1.23
2.25
9.0
9.7
95.58
95.67
%
0.07
215
1795
63
432
1.47
2.24
2.1
1.9
175.80
204.49
pmol/l
0.87
56
414
348
3006
1.19
2.24
2.5
2.4
—
—
—
0
0
180
1454
1.26
2.24
2.4
2.9
66.36
66.49
g/l
0.08
165
1350
78
558
1.41
2.23
1.4
1.3
—
—
—
0
0
117
894
1.33
2.22
1.7
1.7
0.28
0.30
mg/l
0.13
52
419
211
1744
1.23
2.15
7.6
9.1
1.25
1.34
mmol/l
0.96
206
1712
11
42
2.63
2.14
1.5
1.3
0.47
0.34
ug/l
0.51
11
30
39
243
1.62
2.13
1.3
1.2
—
—
—
0
0
249
2096
1.21
2.12
4.1
4.5
230.80
246.14
u/l
0.99
234
2001
33
197
1.69
2.12
1.7
2.3
16.56
24.66
mg/l
—
9
84
105
798
1.33
2.09
1.6
1.5
14.50
10.44
iu/ml
—
5
23
16
75
2.14
2.08
1.0
1.5
104.38
88.58
%
—
8
45
133
1046
1.29
2.07
10.5
12.2
16.57
15.92
%
1.97
127
1010
40
253
1.59
2.07
7.4
6.7
12.15
11.59
mg/l
0.33
35
234
28
162
1.74
2.02
1.1
1.3
0.26
3.02
u/ml
2.62
17
92
72
518
1.40
2.02
2.2
1.6
434.31
518.43
mg/l
1.42
67
492
223
1867
1.22
2.02
2.6
2.4
0.22
0.21
g/l
0.98
206
1748
518
4656
1.15
2.00
5.5
5.4
5.18
2.52
ug/l
0.54
465
4217
92
691
1.35
1.99
1.3
1.4
—
—
—
0
0
66
470
1.42
1.97
1.4
1.7
12228.10
13505.61
e6/l
0.10
49
329
139
1109
1.27
1.95
1.6
1.5
19.53
24.30
iu/l
1.30
117
911
31
187
1.67
1.94
1.0
1.1
4.25
8.56
iu/ml
—
8
45
15
73
2.06
1.80
1.1
1.8
—
—
—
0
0
15
73
2.06
1.80
1.1
1.8
—
—
—
0
0
114
897
1.29
1.80
2.9
3.4
1.02
1.02
ratio
0.22
102
817
76
565
1.36
1.78
1.7
2.0
5.52
3.99
iu/l
0.35
31
234
11
233
0.47
1.77
2.5
2.3
32.18
32.33
pg
0.03
11
233
51
354
1.45
1.77
8.1
9.1
104.29
105.22
mmol/l
0.79
45
321
19
102
1.87
1.76
1.5
1.2
—
—
—
0
0
15
74
2.03
1.75
1.1
1.8
—
—
—
0
0
58
415
1.41
1.72
1.2
1.1
1.77
24.61
au/ml
—
9
98
110
868
1.28
1.71
1.7
1.7
311.86
310.00
mu/l
0.03
102
787
1794
17495
1.15
1.69
5.3
4.9
4.60
4.62
mmol/l
0.46
1701
16494
31
195
1.60
1.68
1.5
1.3
—
—
—
0
0
205
1737
1.20
1.67
9.6
10.1
124.59
121.03
g/l
1.88
198
1701
685
6333
1.12
1.67
3.6
3.5
7.44
7.73
mmol/l
0.85
574
5473
18
97
1.86
1.66
1.9
3.2
163.63
131.25
umol/l
—
8
61
102
806
1.28
1.59
2.3
2.0
40.04
38.80
u/l
0.26
93
729
37
248
1.50
1.55
1.4
1.4
278.42
280.97
mosm/kgh2o
0.29
26
182
69
519
1.34
1.54
3.4
3.4
3.56
3.04
ratio
0.13
46
291
14
71
1.98
1.54
1.4
1.3
—
—
—
0
0
14
71
1.98
1.54
1.4
1.3
—
—
—
0
0
1699
16537
1.13
1.54
4.5
4.1
1.28
1.27
mmol/l
0.21
1587
15366
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
124
1012
1.24
1.49
2.4
2.3
5871.91
6133.60
u/l
0.03
43
389
103
823
1.26
1.49
1.6
1.9
5.74
7.70
iu/ml
0.51
20
188
75
575
1.32
1.48
3.4
3.6
48.43
65.47
mg/l
0.61
68
493
75
575
1.32
1.48
3.4
3.6
43.99
52.70
mg/l
0.21
68
494
62
462
1.35
1.48
2.4
1.8
10493.32
850.20
e6/l
0.46
50
356
83
649
1.29
1.43
1.4
1.7
1.18
1.20
g/l
0.22
78
614
50
362
1.39
1.43
1.6
1.4
—
—
—
0
0
61
457
1.34
1.42
2.4
1.7
22.51
44.95
e6/l
0.40
47
331
70
536
1.32
1.41
1.0
1.1
6.85
6.84
eliau/ml
—
8
77
124
1020
1.23
1.40
3.0
3.5
1.35
1.22
%
0.55
124
1014
66
502
1.32
1.39
1.3
1.5
—
—
—
0
0
101
814
1.25
1.37
1.6
2.1
1.56
1.47
g/l
0.37
85
720
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
17
97
1.76
1.35
1.5
1.4
—
—
—
0
0
17
97
1.76
1.35
1.5
1.4
—
—
—
0
0
37
258
1.44
1.31
1.3
1.3
—
—
—
0
0
37
258
1.44
1.31
1.6
1.6
300.23
331.11
mu/l
0.39
31
209
148
1251
1.20
1.29
1.9
1.9
0.98
1.34
g/l
3.89
140
1161
1777
17398
1.12
1.26
5.2
4.8
1.46
1.46
mmol/l
0.19
1674
16298
14
77
1.82
1.25
2.0
2.6
125.82
80.48
ug/l
0.48
14
77
15
85
1.77
1.23
1.1
1.1
188.70
231.36
iu/ml
0.34
15
85
5
19
2.64
1.21
1.2
1.9
—
—
—
0
0
40
289
1.39
1.19
2.7
3.8
0.98
1.35
%
0.46
32
268
29
198
1.47
1.17
1.1
1.1
—
—
—
0
0
77
616
1.26
1.15
2.8
2.4
10.11
10.41
g/l
0.21
68
557
93
761
1.23
1.15
1.2
1.2
0.30
1.03
u/ml
—
9
56
27
183
1.48
1.13
2.4
3.3
71.05
55.68
%
3.18
20
169
81
654
1.25
1.13
3.3
3.3
3.62
3.52
g/l
0.20
71
626
65
511
1.28
1.12
2.6
2.2
11.49
11.64
mg/l
0.06
65
474
5
113
0.44
1.12
1.4
1.4
130.84
157.32
pmol/l
—
5
113
25
167
1.50
1.12
1.1
1.6
—
—
—
0
0
25
167
1.50
1.12
1.1
1.6
—
—
—
0
0
25
167
1.50
1.12
1.1
1.6
—
—
—
0
0
1611
15721
1.10
1.12
22.5
18.8
13.53
13.53
%
0.03
1595
15524
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
26
178
1.47
1.05
1.0
1.2
—
245.00
—
0
6
5
22
2.28
1.03
4.4
4.1
—
—
—
0
0
9
47
1.92
1.02
2.0
1.5
—
—
—
0
0
65
519
1.26
1.02
1.3
1.6
—
—
—
0
0
86
710
1.22
1.00
2.6
2.4
3.74
3.67
g/l
0.16
78
656
179
1575
1.15
1.00
3.1
3.0
9.77
10.59
g/l
2.72
167
1459
7
35
2.00
1.00
1.3
1.3
—
—
—
0
0
19
123
1.55
0.99
1.3
1.4
—
—
—
0
0
86
711
1.22
0.99
2.6
2.4
4.19
4.20
g/l
0.03
78
655
86
711
1.22
0.99
2.6
2.4
7.10
7.36
g/l
0.72
78
656
47
361
1.31
0.99
1.1
1.1
3.53
6.24
u/ml
0.72
28
178
603
5678
1.09
0.97
4.1
4.2
8.83
8.52
mg/mmol
0.05
372
3617
160
1400
1.15
0.97
3.2
2.7
77.97
69.17
ml/min/173m2
0.57
76
596
24
165
1.46
0.96
2.3
2.5
—
—
—
0
0
14
85
1.65
0.94
1.7
2.3
113.00
144.55
nmol/l
1.24
14
76
81
672
1.21
0.92
2.7
2.4
3.02
2.95
g/l
0.26
73
617
42
322
1.31
0.91
1.3
1.2
—
—
—
0
0
138
1201
1.16
0.91
10.9
11.5
93.86
93.94
%
0.06
138
1193
75
619
1.22
0.90
2.8
2.5
0.38
1.25
g/l
2.92
64
543
74
610
1.22
0.90
1.2
1.1
3.83
3.98
—
10
75
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
19
127
1.50
0.88
1.1
1.1
1.92
3.51
nmol/l
—
8
19
66
539
1.23
0.88
3.1
2.3
0.00
0.02
g/l
1.01
59
487
13
79
1.65
0.88
1.2
1.0
—
—
—
0
0
19
128
1.49
0.86
1.2
1.2
0.58
0.56
ratio
0.12
13
73
48
379
1.27
0.85
2.5
2.4
109.29
112.23
ug/min
0.02
30
233
400
3726
1.09
0.84
4.7
4.5
22.17
21.55
%
0.34
175
1752
79
663
1.20
0.82
1.4
1.3
—
—
—
0
0
55
445
1.24
0.81
1.8
2.2
130.91
131.28
g/l
0.03
45
357
22
155
1.42
0.81
1.4
1.6
25.17
31.27
%
0.33
12
96
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
303
2800
1.10
0.76
3.1
3.3
0.85
0.75
ug/l
0.39
198
1748
10
59
1.70
0.75
1.4
1.6
—
—
—
0
0
21
149
1.41
0.75
1.1
1.2
—
33.00
—
0
7
180
1621
1.12
0.75
2.5
3.0
67.10
71.07
e9/l
0.84
125
1181
22
158
1.40
0.74
1.2
1.1
—
—
—
0
0
38
299
1.28
0.72
1.0
1.1
9.70
2.82
eliau/ml
0.52
17
130
20
142
1.41
0.72
1.2
1.2
—
—
—
0
0
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
20
143
1.40
0.70
1.2
1.2
—
—
—
0
0
9
58
1.55
0.69
2.1
2.6
20.11
15.52
umol/l
—
9
58
47
382
1.24
0.69
1.5
1.5
0.32
0.40
nmol/l
0.47
38
300
41
328
1.25
0.69
1.1
1.1
—
—
—
0
0
78
667
1.18
0.69
1.6
1.5
0.27
11.29
iu/ml
0.49
18
108
192
1748
1.11
0.67
3.1
4.3
21.72
19.72
ug/l
0.04
151
1406
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
5
95
0.53
0.66
1.2
3.2
2.37
1.61
ug/l
—
5
89
573
5469
1.06
0.64
4.3
4.0
0.00
0.00
estimate
1.54
173
1982
581
5548
1.06
0.64
3.3
3.2
0.03
0.22
estimate
0.68
156
1697
40
323
1.24
0.63
1.4
1.3
—
—
—
0
0
23
172
1.34
0.63
1.1
1.1
—
—
—
0
0
62
525
1.19
0.63
3.2
2.4
0.00
0.00
g/l
-0.00
56
460
22
164
1.34
0.62
1.1
1.1
—
—
—
0
0
63
535
1.18
0.62
1.3
1.6
—
—
—
0
0
10
63
1.59
0.61
3.3
2.6
0.62
0.62
mmol/l
—
10
63
88
769
1.15
0.61
1.2
1.3
256.08
224.51
miu/ml
0.25
27
366
22
165
1.34
0.60
1.1
1.1
—
—
—
0
0
29
227
1.28
0.60
1.2
1.3
0.17
0.18
nmol/l
0.37
23
185
24
183
1.31
0.59
6.3
5.0
355.26
56.49
u/ml
—
9
58
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
86
753
1.15
0.59
2.6
1.8
5.61
4.79
mg/l
0.16
69
557
75
650
1.16
0.59
1.4
1.4
—
—
—
0
0
38
309
1.23
0.58
1.2
1.2
1.70
5.00
u/ml
—
10
133
390
3692
1.07
0.57
1.7
1.7
23975232.56
38486638.37
pmol/l
0.24
317
3118
23
176
1.31
0.56
1.4
1.2
—
—
—
0
0
8
124
0.64
0.54
1.0
1.5
—
—
—
0
0
6
98
0.61
0.52
1.2
1.7
—
1427949.88
—
0
8
21
161
1.31
0.51
1.1
1.1
—
—
—
0
0
110
990
1.12
0.51
2.0
3.3
24.53
66.28
u/ml
2.47
101
959
40
333
1.20
0.51
1.5
1.2
548.57
377.00
titre
—
7
20
72
631
1.15
0.51
3.6
3.2
176.03
180.70
%
0.21
64
607
15
110
1.37
0.48
1.1
1.1
—
—
—
0
0
7
46
1.52
0.48
1.1
1.2
—
—
—
0
0
43
366
1.18
0.45
1.2
1.5
—
—
—
0
0
27
219
1.24
0.45
1.1
1.7
—
—
—
0
0
12
86
1.40
0.44
1.2
1.1
—
—
—
0
0
37
437
0.84
0.44
1.5
1.6
50.68
59.03
ug/l
0.79
37
437
18
139
1.30
0.43
1.4
2.5
0.66
0.70
e9/l
0.12
18
134
44
378
1.17
0.42
1.1
1.4
—
—
—
0
0
105
1151
0.91
0.42
1.5
1.6
1084.92
1013.53
mu/l
0.39
87
985
8
57
1.40
0.42
1.0
1.1
27.02
30.71
iu/ml
—
8
57
10
70
1.43
0.41
2.1
1.6
72.16
80.51
nmol/24h
—
10
70
8
58
1.38
0.41
4.8
3.0
10.50
10.34
kpa
—
8
58
8
58
1.38
0.41
4.8
3.0
4.90
4.80
kpa
—
8
58
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
8
59
1.36
0.41
1.0
1.4
94.88
90.49
%
—
8
59
0
17
0.00
0.40
0.0
1.1
—
1.68
—
0
17
334
3187
1.06
0.40
1.5
1.5
—
—
—
0
0
43
497
0.86
0.40
1.3
1.4
245.17
232.31
u/ml
0.14
23
275
8
60
1.33
0.40
1.0
1.4
11.09
8.89
ug/l
—
8
60
202
2147
0.93
0.39
1.9
1.9
3.46
3.47
ratio
0.05
155
1649
159
1483
1.08
0.39
2.1
2.5
0.23
0.43
e6/l
1.44
152
1411
151
1406
1.08
0.38
3.6
3.8
1.23
1.23
mmol/l
0.18
132
1213
68
758
0.89
0.38
1.1
1.1
1.55
1.54
g/l
0.18
68
758
46
526
0.87
0.38
1.3
1.4
—
65.53
—
0
10
31
261
1.19
0.38
1.2
1.3
0.65
7.35
nmol/l
0.50
31
253
25
206
1.22
0.38
1.7
1.7
—
—
—
0
0
8
112
0.71
0.37
1.0
1.6
—
—
—
0
0
8
115
0.69
0.37
1.1
1.2
—
—
—
0
0
31
262
1.19
0.37
1.6
1.7
—
—
—
0
0
48
545
0.88
0.36
1.5
1.6
—
—
—
0
0
36
309
1.17
0.36
2.4
2.5
3.88
7.05
umol/l
1.87
20
235
23
189
1.22
0.36
3.5
1.9
—
—
—
0
0
45
395
1.14
0.35
2.1
1.5
—
—
—
0
0
23
190
1.21
0.34
1.2
1.8
—
—
—
0
0
6
44
1.36
0.34
10.7
6.5
6.67
8.59
%
—
6
44
6
45
1.33
0.33
5.3
6.7
6.88
5.13
kpa
—
6
45
51
453
1.13
0.33
1.3
1.2
—
—
—
0
0
75
683
1.10
0.33
1.3
1.5
—
—
—
0
0
44
388
1.14
0.32
1.1
1.1
2.47
5.06
u/ml
0.97
29
212
59
532
1.11
0.31
1.5
1.7
—
—
—
0
0
23
272
0.84
0.30
2.1
1.9
1.80
1.67
mmol/l
0.22
23
265
16
129
1.24
0.30
1.3
1.4
—
—
—
0
0
15
120
1.25
0.30
1.3
1.1
1.04
1.06
u/l
—
5
58
34
297
1.15
0.29
1.5
1.3
—
—
—
0
0
8
110
0.73
0.28
1.0
1.6
—
—
—
0
0
50
451
1.11
0.27
1.2
1.4
—
—
—
0
0
78
721
1.08
0.27
1.9
1.9
1.65
1.80
ug/l
0.07
64
649
20
236
0.85
0.26
1.2
1.1
—
—
—
0
0
13
104
1.25
0.26
2.9
2.3
2.05
1.85
umol/l
0.47
13
93
18
150
1.20
0.26
1.8
2.6
—
—
—
0
0
39
348
1.12
0.26
1.4
1.8
—
—
—
0
0
23
197
1.17
0.25
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
114
1.23
0.25
1.0
1.1
—
—
—
0
0
27
307
0.88
0.23
2.1
3.9
18.63
29.95
u/ml
1.14
27
299
38
341
1.12
0.23
1.2
1.1
290.44
1823.97
iu/ml
—
8
73
13
106
1.23
0.23
2.9
2.2
27.15
28.01
umol/l
0.09
13
97
12
97
1.24
0.23
39.9
29.7
136.33
129.22
ug/l
0.10
12
81
18
153
1.18
0.22
1.1
1.1
—
—
—
0
0
40
362
1.11
0.22
2.2
2.7
16.72
16.44
%
0.26
40
354
14
116
1.21
0.22
1.0
1.1
1.07
1.05
ratio
0.25
14
99
0
11
0.00
0.21
0.0
4.0
—
—
—
0
0
0
10
0.00
0.21
0.0
4.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
4782.71
—
0
7
0
12
0.00
0.21
0.0
4.1
—
—
—
0
0
8
103
0.78
0.21
1.4
1.2
5.13
9.11
mm/h
—
8
103
66
707
0.93
0.20
1.1
1.1
0.63
0.64
ratio
—
9
80
0
14
0.00
0.20
0.0
2.9
—
3.44
—
0
14
0
14
0.00
0.20
0.0
7.1
—
—
—
0
0
11
90
1.22
0.19
3.6
2.9
388.45
111.38
ug/l
0.33
11
80
14
118
1.19
0.19
1.1
1.2
—
—
—
0
0
12
143
0.84
0.18
1.0
1.7
—
—
—
0
0
18
156
1.16
0.18
1.8
2.4
18.85
32.08
mg/l
1.29
13
109
175
1815
0.96
0.18
3.8
3.3
—
—
—
0
0
149
1431
1.04
0.18
11.0
10.5
24.95
24.87
mmol/l
0.11
149
1423
34
309
1.10
0.18
1.2
1.1
—
—
—
0
0
7
58
1.21
0.18
1.0
1.4
—
—
—
0
0
20
176
1.14
0.17
1.3
1.4
16433.46
142644.22
e6/l
1.34
13
116
46
496
0.93
0.17
1.7
1.8
—
—
—
0
0
10
82
1.22
0.17
1.0
1.1
—
—
—
0
0
155
1608
0.96
0.17
1.7
1.7
3.39
3.45
mmol/l
0.30
109
1112
78
738
1.06
0.17
1.4
1.4
—
—
—
0
0
5
70
0.71
0.16
2.6
4.2
—
—
—
0
0
73
690
1.06
0.16
3.5
3.2
90.71
92.69
%
0.30
68
667
32
349
0.92
0.15
2.1
3.7
58.07
1150.92
u/ml
0.88
27
328
6
78
0.77
0.15
3.2
2.4
—
—
—
0
0
20
178
1.12
0.15
1.1
1.1
20.36
14.73
u/ml
—
5
68
12
102
1.18
0.15
1.8
1.8
—
—
—
0
0
59
556
1.06
0.15
1.1
1.2
3.42
2.64
u/ml
0.17
33
316
61
578
1.06
0.13
1.4
1.5
—
—
—
0
0
34
315
1.08
0.13
1.3
1.2
1.45
3.62
u/ml
1.79
11
109
10
116
0.86
0.12
1.2
2.4
8.22
8.67
mmol/l
—
10
116
47
445
1.06
0.11
5.9
6.1
258.88
444.96
iu/ml
—
8
55
46
436
1.06
0.10
1.7
1.8
—
—
—
0
0
63
656
0.96
0.09
3.0
3.4
28.17
2372.55
u/ml
0.92
51
569
28
262
1.07
0.09
1.4
1.6
—
—
—
0
0
50
478
1.05
0.09
1.1
1.1
1.68
2.01
u/ml
0.14
31
274
11
97
1.13
0.09
1.1
1.2
72.68
84.26
u/l
0.52
11
90
11
97
1.13
0.09
1.1
1.2
7.95
24.70
u/l
3.87
11
90
22
204
1.08
0.08
1.1
1.2
—
33.60
—
0
5
6
58
1.03
0.08
1.2
1.3
—
—
—
0
0
44
420
1.05
0.08
1.7
1.6
138.21
137.07
au/ml
0.02
14
125
5
60
0.83
0.08
1.0
1.1
99.72
44.36
u/ml
—
5
60
7
68
1.03
0.07
1.1
1.9
42.03
40.29
g/l
—
7
68
61
589
1.04
0.07
1.5
1.5
0.87
0.95
ratio
1.23
32
361
61
589
1.04
0.07
1.5
1.5
1.18
1.22
ratio
0.11
32
361
61
589
1.04
0.07
1.5
1.5
1.11
1.14
ratio
0.07
32
361
15
137
1.10
0.07
1.9
2.2
0.87
1.66
u/field
—
8
79
8
77
1.04
0.07
1.0
1.0
—
—
—
0
0
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
7
84
0.83
0.07
3.6
4.0
1.07
1.23
%
—
7
84
17
157
1.08
0.07
1.6
1.6
—
—
—
0
0
9
102
0.88
0.06
1.9
2.1
—
—
—
0
0
36
345
1.04
0.06
1.1
1.1
0.09
1.02
u/ml
0.87
16
125
62
638
0.97
0.06
1.5
1.5
69.60
60.72
ug/l
0.60
50
546
48
495
0.97
0.05
1.1
1.1
7.37
5.87
u/ml
0.23
29
294
12
110
1.09
0.05
1.2
1.1
1668.50
1534.45
miu/ml
0.16
12
110
47
483
0.97
0.04
1.1
1.1
0.52
1.46
u/ml
1.46
27
234
19
200
0.95
0.03
1.5
1.4
1381.92
1857.35
e6/l
0.40
13
130
31
299
1.04
0.03
1.1
1.5
—
—
—
0
0
41
421
0.97
0.03
1.6
1.9
0.72
0.87
nmol/l
0.73
35
364
18
171
1.05
0.03
1.4
1.4
—
79.50
—
0
6
12
128
0.94
0.02
3.0
2.4
666.71
636.33
ml
—
7
85
17
178
0.95
0.02
1.5
1.4
22353.30
67238.79
e6/l
—
10
94
15
144
1.04
0.00
1.7
1.9
3.01
3.92
mg/l
0.97
15
139
16
154
1.04
0.00
2.9
1.9
—
—
—
0
0
15
152
0.99
0.00
1.2
1.4
—
—
—
0
0
13
128
1.02
0.00
1.2
1.5
—
—
—
0
0
33
328
1.01
0.00
1.2
1.1
4.30
3.41
—
7
47
13
133
0.98
0.00
3.8
1.4
75.77
77.04
umol/l
0.09
13
133
11
107
1.03
0.00
2.1
1.8
133.36
106.76
ng/l
0.23
11
107
37
369
1.00
0.00
5.4
4.5
5.25
5.02
kpa
0.74
37
362
40
396
1.01
0.00
1.7
1.7
—
—
—
0
0
10
104
0.96
0.00
1.1
2.0
—
—
—
0
0
10
104
0.96
0.00
1.1
2.0
—
—
—
0
0
17
168
1.01
0.00
1.0
1.0
—
—
—
0
0
11
108
1.02
0.00
1.1
1.6
0.55
0.49
e9/l
0.32
11
108
32
322
0.99
0.00
4.2
3.5
0.76
0.82
nmol/l
0.32
27
267
39
385
1.01
0.00
4.2
3.7
25.51
25.95
mg/l
0.03
27
276
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
95
0.95
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
98
0.92
-0.00
1.3
1.4
5.02
5.91
mmol/l
—
9
98
0
7
0.00
-0.00
0.0
1.0
—
1431.14
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.2
419.00
294.66
pmol/l
—
5
35
0
8
0.00
-0.00
0.0
5.3
—
401.50
—
0
8
5
55
0.91
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
299.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
7532.00
—
0
5
0
5
0.00
-0.00
0.0
8.0
—
84.80
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_FOREI_BODY_RESPI_TRACT – Foreign body in respiratory tract
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).